{"filter":{"intervention":"antibiotic"},"n_projects":120,"projects":[{"accession":"PRJEB28097","age_categories":{"adult":1602,"elderly":11},"countries":{},"first_public_year":"2018","gbp_per_sample_median":1.18,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"healthy_control":1613},"intervention_design":"randomized_controlled_trial","intervention_detail":"11-strain probiotic vs placebo; post-antibiotic probiotic vs autologous FMT","interventions":["antibiotic","fmt","probiotic"],"n_samples":1613,"papers":[{"doi":"10.1186/s40168-021-01015-y","pmcid":"PMC7931531","pmid":"33658077","title":"Accurate and sensitive detection of microbial eukaryotes from whole metagenome shotgun sequencing."},{"doi":"10.1128/mbio.03456-22","pmcid":"PMC9972980","pmid":"36719226","title":"Strains Colonizing Different Intestinal Sites within an Individual Are Derived from a Single Founder Population."},{"doi":"10.1038/s41564-021-00920-0","pmcid":"PMC8318886","pmid":"34226711","title":"Probiotics impact the antibiotic resistance gene reservoir along the human GI tract in a person-specific and antibiotic-dependent manner."},{"doi":"10.1038/s42003-021-02724-8","pmcid":"PMC8523657","pmid":"34663913","title":"Probiotic consumption influences universal adaptive mutations in indigenous human and mouse gut microbiota."},{"doi":"10.3390/life11111246","pmcid":"PMC8620312","pmid":"34833122","title":"Lacticaseibacillus paracasei: Occurrence in the Human Gut Microbiota and K-Mer-Based Assessment of Intraspecies Diversity."}],"sample_intervention_arms":{"antibiotic":555,"bowel_preparation":20,"fmt":60,"no_intervention":579,"placebo":47,"probiotic":240},"sex":{"female":687,"male":926},"title":"(1) Personalized microbiome and host features resist gut mucosal colonization by empiric probiotics (2) Post-antibiotic gut mucosal microbiome reconstitution is impaired by probiotics and improved by autologous FMT","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB28097","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB28097_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB28097.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB28097.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB28097.csv.gz"}},{"accession":"PRJNA643353","age_categories":{"adult":1156,"elderly":36},"countries":{"CN":1192},"first_public_year":"2021","gbp_per_sample_median":10.73,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"type2_diabetes":1192},"intervention_design":"randomized_controlled_trial","intervention_detail":"Berberine and/or probiotics vs placebo, with gentamycin run-in pretreatment","interventions":["antibiotic","drug_therapy","probiotic"],"n_samples":1192,"papers":[{"doi":"10.1038/s41467-020-18414-8","pmcid":"PMC7538905","pmid":"33024120","title":"Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study)."},{"doi":"10.1080/19490976.2021.2003176","pmcid":"PMC8726654","pmid":"34923903","title":"Combined berberine and probiotic treatment as an effective regimen for improving postprandial hyperlipidemia in type 2 diabetes patients: a double blinded placebo controlled randomized study."},{"doi":"10.1038/s41564-021-00920-0","pmcid":"PMC8318886","pmid":"34226711","title":"Probiotics impact the antibiotic resistance gene reservoir along the human GI tract in a person-specific and antibiotic-dependent manner."},{"doi":"10.1002/imt2.179","pmcid":"PMC11170963","pmid":"38882498","title":"Deciphering unique and shared interactions between the human gut microbiota and oral antidiabetic drugs."},{"doi":"10.1016/j.heliyon.2024.e37986","pmcid":"PMC11438002","pmid":"39347390","title":"Clinical significance of the genetically variable landscape of the gut microbiome in patients with gestational diabetes mellitus patients."}],"sample_intervention_arms":{"antibiotic":403,"drug_therapy":85,"no_intervention":405,"other_intervention":104,"placebo":97,"probiotic":98},"sex":{"female":146,"male":216},"title":"The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA643353","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA643353_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA643353.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA643353.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA643353.csv.gz"}},{"accession":"PRJNA974858","age_categories":{"adult":1040},"countries":{"US":1040},"first_public_year":"2024","gbp_per_sample_median":5.29,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":1040},"intervention_design":"non_randomized_controlled","intervention_detail":"Ciprofloxacin 500mg twice daily for 5 days vs unexposed controls","interventions":["antibiotic"],"n_samples":1040,"papers":[{"doi":"10.1038/s41586-025-08781-x","pmcid":"PMC12168174","pmid":"40269166","title":"Brief antibiotic use drives human gut bacteria towards low-cost resistance."}],"sample_intervention_arms":{},"sex":{},"title":"Temporal shotgun sequencing of the gut microbiota of healthy adults taking ciprofloxacin","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA974858","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA974858_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA974858.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA974858.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA974858.csv.gz"}},{"accession":"PRJNA1277853","age_categories":{"unknown":682},"countries":{"BE":51,"UG":114,"ZA":297,"ZM":110,"ZW":110},"first_public_year":"2026","gbp_per_sample_median":0.13,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_disease":51,"other_infection":631},"intervention_design":"randomized_controlled_trial","intervention_detail":"Randomized to continued IV antibiotics vs step-down oral amoxicillin/co-amoxiclav, varying durations","interventions":["antibiotic"],"n_samples":682,"papers":[{"doi":"10.1038/s44259-026-00216-5","pmcid":"PMC13530132","pmid":"42168578","title":"Impact of co-amoxiclav versus amoxicillin on the gastrointestinal microbiota in sub-Saharan children hospitalized with pneumonia."}],"sample_intervention_arms":{},"sex":{},"title":"PediCAP metagenomics and metaserotyping","trial_population_condition":"unknown","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1277853","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1277853_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1277853.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1277853.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1277853.csv.gz"}},{"accession":"PRJNA1106565","age_categories":{"infant":669},"countries":{"US":669},"first_public_year":"2024","gbp_per_sample_median":2.13,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":669},"intervention_design":"observational_with_procedure","intervention_detail":"Observed antibiotic exposure (predominantly amoxicillin) in infants, not trial-assigned","interventions":["antibiotic"],"n_samples":669,"papers":[{"doi":"10.1128/mbio.01534-24","pmcid":"PMC11558993","pmid":"39440978","title":"Metal availability shapes early life microbial ecology and community succession."},{"doi":"10.1186/s40168-024-01999-3","pmcid":"PMC11761179","pmid":"39856742","title":"Antibiotic exposure is associated with minimal gut microbiome perturbations in healthy term infants."},{"doi":"10.1016/j.chom.2025.07.003","pmcid":"PMC12375414","pmid":"40763731","title":"Amino acid competition shapes Acinetobacter baumannii gut carriage."}],"sample_intervention_arms":{},"sex":{},"title":"Antibiotic exposure is associated with minimal gut microbiome perturbations in healthy term infants","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1106565","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1106565_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1106565.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1106565.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1106565.csv.gz"}},{"accession":"PRJNA1110178","age_categories":{"unknown":662},"countries":{"GB":662},"first_public_year":"2024","gbp_per_sample_median":8.07,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"observational_with_procedure","intervention_detail":"Clinical antibiotic treatment in trauma patients, observed pre/post","interventions":["antibiotic"],"n_samples":662,"papers":[{"doi":"10.1016/j.isci.2024.110783","pmcid":"PMC11403444","pmid":"39286492","title":"Metagenomic changes in response to antibiotic treatment in severe orthopedic trauma patients."}],"sample_intervention_arms":{},"sex":{},"title":"Metagenomics of rib fracture cases and controls","trial_population_condition":"other_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1110178","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1110178_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1110178.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1110178.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1110178.csv.gz"}},{"accession":"PRJNA1356862","age_categories":{"child":630},"countries":{"NE":630},"first_public_year":"2026","gbp_per_sample_median":0.56,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"randomized_controlled_trial","intervention_detail":"Mass drug administration of azithromycin vs placebo, twice-annual, children 1-59 months","interventions":["antibiotic"],"n_samples":630,"papers":[{"doi":"10.1038/s41467-026-68691-y","pmcid":"PMC12957345","pmid":"41611691","title":"Geographic spillover of antimicrobial resistance from mass distribution of azithromycin."}],"sample_intervention_arms":{"no_intervention":316},"sex":{},"title":"Geographic spillover of antimicrobial resistance from mass distribution of azithromycin","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1356862","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1356862_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1356862.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1356862.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1356862.csv.gz"}},{"accession":"PRJEB105465","age_categories":{"adult":548},"countries":{"SE":548},"first_public_year":"2026","gbp_per_sample_median":11.25,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"healthy_control":548},"intervention_design":"randomized_controlled_trial","intervention_detail":"Randomized 5-day course: nitrofurantoin, pivmecillinam, sulfamethoxazole/trimethoprim, ceftibuten, ciprofloxacin, or untreated","interventions":["antibiotic"],"n_samples":548,"papers":[],"sample_intervention_arms":{"antibiotic":387,"no_intervention":161},"sex":{"female":269,"male":279},"title":"Effects of antibiotic treatment on normal intestinal flora (ARG-study)","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB105465","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB105465_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB105465.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB105465.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB105465.csv.gz"}},{"accession":"PRJNA1307073","age_categories":{"unknown":545},"countries":{"CN":545},"first_public_year":"2026","gbp_per_sample_median":6.91,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"gi_infection_or_diarrhoea":545},"intervention_design":"non_randomized_controlled","intervention_detail":"H. pylori eradication: bismuth quadruple, dual, tailored therapy","interventions":["antibiotic"],"n_samples":545,"papers":[],"sample_intervention_arms":{},"sex":{},"title":"SPATIOTEMPORAL EFFECT OF DIFFERENT ERADICATION THERAPIES FOR HELICOBACTER PYLORI INFECTION ON THE COMPOSITION AND FUNCTION OF THE WHOLE GASTROINTESTINAL MICROBIOTA PART 1","trial_population_condition":"gi_infection_or_diarrhoea","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1307073","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1307073_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1307073.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1307073.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1307073.csv.gz"}},{"accession":"PRJNA1079705","age_categories":{"child":494},"countries":{"US":494},"first_public_year":"2024","gbp_per_sample_median":14.39,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"randomized_controlled_trial","intervention_detail":"BB-12 probiotic yogurt vs control yogurt, with prescribed antibiotics","interventions":["antibiotic","probiotic"],"n_samples":494,"papers":[{"doi":"10.1038/s41598-026-39826-4","pmcid":"PMC13000283","pmid":"41699149","title":"Probiotic intervention not beneficial to prevent antibiotic-associated diarrhea in absence of antibiotic-induced microbiome disruption."}],"sample_intervention_arms":{},"sex":{},"title":"Efficacy and Safety of BB-12 Supplemented Strawberry Yogurt For Healthy Children on Antibiotics (PLAY ON)","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1079705","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1079705_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1079705.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1079705.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1079705.csv.gz"}},{"accession":"PRJNA675301","age_categories":{"adult":474},"countries":{"US":474},"first_public_year":"2020","gbp_per_sample_median":1.96,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"single_arm_before_after","intervention_detail":"Vegan, omnivore, or fiber-free EEN diet with antibiotic microbiota depletion, longitudinal","interventions":["antibiotic","diet_intervention"],"n_samples":474,"papers":[{"doi":"10.1016/j.chom.2020.12.012","pmcid":"PMC8022197","pmid":"33440171","title":"Role of dietary fiber in the recovery of the human gut microbiome and its metabolome."},{"doi":"10.1016/j.cell.2023.06.010","pmcid":"PMC10421625","pmid":"37541197","title":"A widely distributed gene cluster compensates for uricase loss in hominids."},{"doi":"10.1172/jci174726","pmcid":"PMC11060737","pmid":"38512401","title":"Dietary carbohydrates regulate intestinal colonization and dissemination of Klebsiella pneumoniae."},{"doi":"10.1186/s13059-024-03453-x","pmcid":"PMC11657513","pmid":"39696594","title":"TEMPTED: time-informed dimensionality reduction for longitudinal microbiome studies."},{"doi":"10.1371/journal.pcbi.1014486","pmcid":"PMC13362426","pmid":"42406847","title":"Extracting host-specific developmental signatures from longitudinal microbiome data."}],"sample_intervention_arms":{"diet_intervention":434},"sex":{},"title":"Role of Diet in the Reconstitution of the Human Gut Microbiome and its Metabolome","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA675301","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA675301_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA675301.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA675301.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA675301.csv.gz"}},{"accession":"PRJNA1337442","age_categories":{"unknown":450},"countries":{"NE":450},"first_public_year":"2026","gbp_per_sample_median":1.71,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"randomized_controlled_trial","intervention_detail":"Azithromycin mass drug administration vs placebo, semiannual, 2 years","interventions":["antibiotic"],"n_samples":450,"papers":[{"doi":"10.1038/s41591-026-04217-9","pmcid":"PMC13004693","pmid":"41845058","title":"Mass azithromycin distribution and antibiotic resistance in the gut and nasopharynx: a cluster-randomized trial."}],"sample_intervention_arms":{},"sex":{"female":207,"male":243},"title":"Effect of Mass Azithromycin Distribution on Antibiotic Resistance in the Gut and Nasopharynx: A Cluster-Randomized Trial","trial_population_condition":"unknown","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1337442","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1337442_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1337442.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1337442.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1337442.csv.gz"}},{"accession":"PRJNA755324","age_categories":{"adult":450},"countries":{"US":450},"first_public_year":"2022","gbp_per_sample_median":6.32,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"randomized_controlled_trial","intervention_detail":"VE303 (8-strain LBP) dosed after vancomycin pretreatment, phase 1a/b","interventions":["antibiotic","live_biotherapeutic"],"n_samples":450,"papers":[{"doi":"10.1016/j.chom.2022.03.016","pmcid":null,"pmid":"35421353","title":"Colonization of the live biotherapeutic product VE303 and modulation of the microbiota and metabolites in healthy volunteers."},{"doi":"10.3390/pharmaceutics17121603","pmcid":"PMC12736906","pmid":"41471117","title":"<i>Flavonifractor plautii</i> as a Next-Generation Probiotic Enhancing the NGP F/P Index in a Simulated Human Gut Microbiome Ecosystem."},{"doi":"10.1371/journal.pbio.3003638","pmcid":"PMC12919772","pmid":"41712536","title":"Metabolic modeling reveals determinants of prebiotic and probiotic treatment efficacy across multiple human intervention trials."}],"sample_intervention_arms":{"no_intervention":64},"sex":{},"title":"Colonization of the Live Biotherapeutic Product VE303 and Modulation of the Microbiota and Metabolites in Healthy Volunteers","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA755324","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA755324_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA755324.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA755324.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA755324.csv.gz"}},{"accession":"PRJNA739008","age_categories":{"child":51,"infant":380,"unknown":3},"countries":{"NE":434},"first_public_year":"2023","gbp_per_sample_median":1.39,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":true,"health_conditions":{"healthy_control":38,"malnutrition":396},"intervention_design":"randomized_controlled_trial","intervention_detail":"Amoxicillin prophylaxis vs placebo for severe acute malnutrition","interventions":["antibiotic"],"n_samples":434,"papers":[{"doi":"10.1016/s2666-5247(23)00213-6","pmcid":"PMC10620469","pmid":"37866373","title":"Effect of amoxicillin on the gut microbiome of children with severe acute malnutrition in Madarounfa, Niger: a retrospective metagenomic analysis of a placebo-controlled trial."}],"sample_intervention_arms":{"antibiotic":168,"no_intervention":111,"placebo":153},"sex":{},"title":"Effect of amoxicillin prophylaxis on gut microbiome and resistome for severe acute malnutrition in Niger","trial_population_condition":"malnutrition","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA739008","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA739008_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA739008.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA739008.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA739008.csv.gz"}},{"accession":"PRJNA489090","age_categories":{"infant":375,"neonate":54},"countries":{"US":429},"first_public_year":"2019","gbp_per_sample_median":1.08,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"observational_with_procedure","intervention_detail":"Clinical antibiotic exposure/therapy in hospitalized preterm infants","interventions":["antibiotic"],"n_samples":429,"papers":[{"doi":"10.1080/19490976.2021.1940792","pmcid":"PMC8284144","pmid":"34264786","title":"Antibiotic-driven intestinal dysbiosis in pediatric short bowel syndrome is associated with persistently altered microbiome functions and gut-derived bloodstream infections."},{"doi":"10.1186/s13059-021-02463-3","pmcid":"PMC8383385","pmid":"34429130","title":"Deterministic transition of enterotypes shapes the infant gut microbiome at an early age."},{"doi":"10.1038/s41467-022-32805-z","pmcid":"PMC9437082","pmid":"36050292","title":"A compendium of 32,277 metagenome-assembled genomes and over 80 million genes from the early-life human gut microbiome."},{"doi":"10.1038/s43705-021-00003-5","pmcid":"PMC9723731","pmid":"36717704","title":"Persistence of birth mode-dependent effects on gut microbiome composition, immune system stimulation and antimicrobial resistance during the first year of life."},{"doi":"10.1038/s41522-023-00392-6","pmcid":"PMC10175488","pmid":"37169786","title":"Comprehensive insights from composition to functional microbe-based biodiversity of the infant human gut microbiota."}],"sample_intervention_arms":{},"sex":{"female":183,"male":246},"title":"Human infant gut metagenome, infant shotgun sequencing","trial_population_condition":"preterm_nicu","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA489090","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA489090_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA489090.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA489090.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA489090.csv.gz"}},{"accession":"PRJNA945408","age_categories":{"adolescent":2,"adult":414},"countries":{"HN":174,"KE":242},"first_public_year":"2023","gbp_per_sample_median":1.18,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"gi_infection_or_diarrhoea":416},"intervention_design":"randomized_controlled_trial","intervention_detail":"Single-dose antibiotic treatment regimens and rifaximin prophylaxis for travelers' diarrhea","interventions":["antibiotic"],"n_samples":416,"papers":[{"doi":"10.1128/mbio.02790-23","pmcid":"PMC10790752","pmid":"38085102","title":"Gut microbiome and antibiotic resistance effects during travelers' diarrhea treatment and prevention."}],"sample_intervention_arms":{"antibiotic":166,"placebo":66},"sex":{"female":20,"male":386},"title":"Impact of antibiotic regimens for the prevention and treatment of travelers diarrhea Prevent TD and TrEAT TD","trial_population_condition":"gi_infection_or_diarrhoea","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA945408","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA945408_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA945408.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA945408.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA945408.csv.gz"}},{"accession":"PRJNA604820","age_categories":{"adult":377},"countries":{"US":377},"first_public_year":"2022","gbp_per_sample_median":1.7,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":377},"intervention_design":"randomized_controlled_trial","intervention_detail":"Doxycycline, cephalexin, or TMP/SMX given to healthy volunteers","interventions":["antibiotic"],"n_samples":377,"papers":[{"doi":"10.1126/scitranslmed.abd8077","pmcid":"PMC8878148","pmid":"34936382","title":"Alterations of human skin microbiome and expansion of antimicrobial resistance after systemic antibiotics."},{"doi":"10.1016/j.xcrm.2023.101205","pmcid":"PMC10591041","pmid":"37757827","title":"Expanded microbiome niches of RAG-deficient patients."},{"doi":"10.3390/microorganisms11102560","pmcid":"PMC10609127","pmid":"37894218","title":"A Pipeline for Constructing Reference Genomes for Large Cohort-Specific Metagenome Compression."},{"doi":"10.3390/microorganisms12102086","pmcid":"PMC11510655","pmid":"39458395","title":"Oral Microbial Translocation Genes in Gastrointestinal Cancers: Insights from Metagenomic Analysis."}],"sample_intervention_arms":{},"sex":{},"title":"Skin metagenome from antibiotics treated healthy human subjects","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA604820","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA604820_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA604820.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA604820.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA604820.csv.gz"}},{"accession":"PRJNA589866","age_categories":{"adult":135,"elderly":214},"countries":{"BG":107,"HU":32,"PL":36,"RO":87,"RS":81,"US":6},"first_public_year":"2020","gbp_per_sample_median":7.45,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{},"intervention_design":"randomized_controlled_trial","intervention_detail":"Ribaxamase (oral beta-lactamase) vs placebo with IV ceftriaxone","interventions":["antibiotic","drug_therapy"],"n_samples":349,"papers":[{"doi":"10.2147/idr.s260258","pmcid":"PMC7383106","pmid":"32801790","title":"Ribaxamase, an Orally Administered β-Lactamase, Diminishes Changes to Acquired Antimicrobial Resistance of the Gut Resistome in Patients Treated with Ceftriaxone."}],"sample_intervention_arms":{"drug_therapy":129,"no_intervention":119,"placebo":101},"sex":{"female":139,"male":207},"title":"human gut metagenome Metagenome","trial_population_condition":"gi_infection_or_diarrhoea","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA589866","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA589866_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA589866.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA589866.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA589866.csv.gz"}},{"accession":"PRJNA922086","age_categories":{"adult":335},"countries":{"FR":335},"first_public_year":"2024","gbp_per_sample_median":6.49,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"intervention_cohort":335},"intervention_design":"unknown","intervention_detail":"","interventions":[],"n_samples":335,"papers":[{"doi":"10.1038/s41467-024-52373-8","pmcid":"PMC11402973","pmid":"39278946","title":"The DAV132 colon-targeted adsorbent does not interfere with plasma concentrations of antibiotics but prevents antibiotic-related dysbiosis: a randomized phase I trial in healthy volunteers."},{"doi":"10.1080/19490976.2024.2442523","pmcid":"PMC12931723","pmid":"39711113","title":"A modelling framework to characterize the impact of antibiotics on the gut microbiota diversity."},{"doi":"10.1007/s10096-025-05184-8","pmcid":null,"pmid":"40504338","title":"Antibiotic-related dysbiosis of gut microbiota in healthy volunteers: a comparative study of ceftazidime-avibactam, piperacillin-tazobactam, and ceftriaxone."}],"sample_intervention_arms":{"antibiotic":195,"no_intervention":140,"other_intervention":135},"sex":{"female":156,"male":179},"title":"Deleterious impact of beta-lactam antibiotics on intestinal microbiome of human healthy volunteers and protection with co-administration of the DAV132 colon-targeted adsorbent.","trial_population_condition":"unknown","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA922086","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA922086_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA922086.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA922086.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA922086.csv.gz"}},{"accession":"PRJNA993161","age_categories":{"adult":262,"elderly":54},"countries":{"US":316},"first_public_year":"2023","gbp_per_sample_median":2.27,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":316},"intervention_design":"randomized_controlled_trial","intervention_detail":"Complex oligosaccharide with/without probiotic in antibiotic-treated healthy volunteers","interventions":["antibiotic","prebiotic_or_fibre","probiotic"],"n_samples":316,"papers":[{"doi":"10.1016/j.chom.2023.08.004","pmcid":null,"pmid":"37657443","title":"Precision modulation of dysbiotic adult microbiomes with a human-milk-derived synbiotic reshapes gut microbial composition and metabolites."}],"sample_intervention_arms":{},"sex":{"female":148,"male":168},"title":"Impact of complex oligosaccharides and a probiotic on the antibiotic-treated human microbiome","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA993161","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA993161_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA993161.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA993161.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA993161.csv.gz"}},{"accession":"PRJNA1074135","age_categories":{"unknown":295},"countries":{"BE":27,"CH":180,"PL":88},"first_public_year":"2024","gbp_per_sample_median":0.67,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{},"intervention_design":"observational_with_procedure","intervention_detail":"","interventions":[],"n_samples":295,"papers":[{"doi":"10.1016/j.ijantimicag.2024.107259","pmcid":null,"pmid":"38936492","title":"Long-term effects of ciprofloxacin treatment on the gastrointestinal and oropharyngeal microbiome are more pronounced after longer antibiotic courses."}],"sample_intervention_arms":{"antibiotic":211,"no_intervention":84},"sex":{},"title":"Long-term effects of ciprofloxacin treatment on the gastrointestinal and oropharyngeal microbiome are more pronounced after longer antibiotic courses","trial_population_condition":"gi_infection_or_diarrhoea","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1074135","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1074135_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1074135.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1074135.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1074135.csv.gz"}},{"accession":"PRJNA664754","age_categories":{"adult":289},"countries":{"US":289},"first_public_year":"2022","gbp_per_sample_median":1.18,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":289},"intervention_design":"single_arm_before_after","intervention_detail":"4 common antibiotic regimens, pre/post sampling 6 months","interventions":["antibiotic"],"n_samples":289,"papers":[{"doi":"10.1016/j.celrep.2022.110649","pmcid":"PMC9066705","pmid":"35417701","title":"Acute and persistent effects of commonly used antibiotics on the gut microbiome and resistome in healthy adults."},{"doi":"10.3390/nu15183925","pmcid":"PMC10536327","pmid":"37764709","title":"Uncovering Predictive Factors and Interventions for Restoring Microecological Diversity after Antibiotic Disturbance."},{"doi":"10.1016/j.eclinm.2024.102490","pmcid":"PMC11133793","pmid":"38813445","title":"Gut microbiome correlates of recurrent urinary tract infection: a longitudinal, multi-center study."},{"doi":"10.1016/j.chom.2024.12.002","pmcid":"PMC11717617","pmid":"39731916","title":"Commensal-pathogen dynamics structure disease outcomes during Clostridioides difficile colonization."}],"sample_intervention_arms":{},"sex":{"female":143,"male":146},"title":"Fecal metagenomes of healthy volunteers","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA664754","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA664754_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA664754.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA664754.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA664754.csv.gz"}},{"accession":"PRJNA715245","age_categories":{"adult":281},"countries":{"US":281},"first_public_year":"2022","gbp_per_sample_median":6.57,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{},"intervention_design":"randomized_controlled_trial","intervention_detail":"Amoxicillin or azithromycin vs placebo (vitamin C), 3 or 7 days","interventions":["antibiotic"],"n_samples":281,"papers":[{"doi":"10.1186/s12866-023-02949-z","pmcid":"PMC10394940","pmid":"37528343","title":"Common antibiotics, azithromycin and amoxicillin, affect gut metagenomics within a household"}],"sample_intervention_arms":{"antibiotic":113,"no_intervention":56,"placebo":112},"sex":{},"title":"human gut metagenome Metagenome","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA715245","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA715245_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA715245.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA715245.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA715245.csv.gz"}},{"accession":"PRJEB58157","age_categories":{"adult":277},"countries":{"FR":277},"first_public_year":"2023","gbp_per_sample_median":3.04,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":277},"intervention_design":"single_arm_before_after","intervention_detail":"Healthy volunteers treated with cefotaxime or ceftriaxone for 3 days","interventions":["antibiotic"],"n_samples":277,"papers":[{"doi":"10.1186/s40168-023-01746-0","pmcid":"PMC10929231","pmid":"38468305","title":"Perturbation and resilience of the gut microbiome up to 3 months after β-lactams exposure in healthy volunteers suggest an important role of microbial β-lactamases."}],"sample_intervention_arms":{"antibiotic":277},"sex":{},"title":"Perturbation and resilience of the gut microbiome three months after β-lactams exposure in healthy volunteers suggest an important role of endogenous β-lactamases","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB58157","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB58157_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB58157.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB58157.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB58157.csv.gz"}},{"accession":"PRJNA1463324","age_categories":{"adult":273},"countries":{"BE":273},"first_public_year":"2026","gbp_per_sample_median":1.37,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"healthy_control":273},"intervention_design":"randomized_controlled_trial","intervention_detail":"Oral vancomycin pretreatment then VE202 16-strain bacterial consortium, single/multiple dose","interventions":["antibiotic","live_biotherapeutic"],"n_samples":273,"papers":[{"doi":"10.1097/meg.0000000000003098","pmcid":null,"pmid":"41342324","title":"A randomized, double-blind, placebo-controlled, single- and multiple-dose phase 1 study of VE202, a defined bacterial consortium for treatment of inflammatory bowel disease: safety and colonization dy"}],"sample_intervention_arms":{"live_biotherapeutic":174,"no_intervention":70,"placebo":29},"sex":{},"title":"VE202 phase 1 stool metagenomes","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1463324","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1463324_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1463324.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1463324.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1463324.csv.gz"}},{"accession":"PRJNA847068","age_categories":{"adult":240},"countries":{"US":240},"first_public_year":"2022","gbp_per_sample_median":0.08,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":240},"intervention_design":"randomized_controlled_trial","intervention_detail":"Ibezapolstat vs vancomycin vs placebo, Phase I healthy volunteers","interventions":["antibiotic"],"n_samples":240,"papers":[{"doi":"10.1128/aac.02244-21","pmcid":"PMC9380534","pmid":"35862742","title":"Functional and Metagenomic Evaluation of Ibezapolstat for Early Evaluation of Anti-Recurrence Effects in Clostridioides difficile Infection."}],"sample_intervention_arms":{},"sex":{},"title":"Ibezapolstat Microbiome Studies","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA847068","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA847068_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA847068.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA847068.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA847068.csv.gz"}},{"accession":"PRJNA737472","age_categories":{"adult":224},"countries":{"US":224},"first_public_year":"2022","gbp_per_sample_median":15.09,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":true,"health_conditions":{"healthy_control":42,"ulcerative_colitis":182},"intervention_design":"randomized_controlled_trial","intervention_detail":"FMT with antibiotic pretreatment vs none; capsule vs enema maintenance, 2x2 factorial","interventions":["antibiotic","fmt"],"n_samples":224,"papers":[{"doi":"10.1038/s41598-022-09307-5","pmcid":"PMC8976058","pmid":"35365713","title":"Strain-resolved analysis in a randomized trial of antibiotic pretreatment and maintenance dose delivery mode with fecal microbiota transplant for ulcerative colitis."},{"doi":"10.3389/fbinf.2022.867386","pmcid":"PMC9580935","pmid":"36304283","title":"Scalable Microbial Strain Inference in Metagenomic Data Using StrainFacts."},{"doi":"10.1038/s41598-024-62463-8","pmcid":"PMC11316000","pmid":"39122767","title":"Sustained mucosal colonization and fecal metabolic dysfunction by Bacteroides associates with fecal microbial transplant failure in ulcerative colitis patients."},{"doi":"10.1101/gr.279543.124","pmcid":"PMC12047655","pmid":"40210439","title":"Accurate estimation of intraspecific microbial gene content variation in metagenomic data with MIDAS v3 and StrainPGC."},{"doi":"10.1016/s0016-5085(20)30716-2","pmcid":null,"pmid":null,"title":"36 ANTIBIOTIC PRETREATMENT PRIOR TO FECAL MICROBIOTA TRANSPLANTATION INCREASES RATES OF REMISSION IN PATIENTS WITH MILD TO MODERATE ULCERATIVE COLITIS: RESULTS FROM A PILOT RANDOMIZED CLINICAL TRIAL"}],"sample_intervention_arms":{"antibiotic":74,"fmt":155,"no_intervention":69},"sex":{"female":69,"male":113},"title":"Microbiome sequencing of ulcerative colitis patients receiving fecal microbiota transplantation","trial_population_condition":"ulcerative_colitis","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA737472","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA737472_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA737472.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA737472.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA737472.csv.gz"}},{"accession":"PRJNA971895","age_categories":{"infant":209},"countries":{"IE":209},"first_public_year":"2023","gbp_per_sample_median":1.5,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"observational_with_procedure","intervention_detail":"Benzylpenicillin and gentamicin exposure in first 4 days of life","interventions":["antibiotic"],"n_samples":209,"papers":[{"doi":"10.1186/s40168-023-01732-6","pmcid":"PMC10837951","pmid":"38310316","title":"Early life exposure of infants to benzylpenicillin and gentamicin is associated with a persistent amplification of the gut resistome."}],"sample_intervention_arms":{},"sex":{},"title":"Resismet","trial_population_condition":"unknown","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA971895","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA971895_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA971895.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA971895.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA971895.csv.gz"}},{"accession":"PRJNA1314234","age_categories":{"unknown":194},"countries":{"CA":194},"first_public_year":"2025","gbp_per_sample_median":3.05,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"single_arm_before_after","intervention_detail":"FMT from ir-colitis patient into antibiotic-pretreated tumor-bearing mice","interventions":["antibiotic","fmt"],"n_samples":194,"papers":[{"doi":"10.1186/s40168-026-02419-4","pmcid":"PMC13288583","pmid":"42083059","title":"Metagenomics and culturomics reveal the dual role of the gut microbiome in the development of immune-related toxicities and the efficacy of immune checkpoint inhibitors in cancer."}],"sample_intervention_arms":{},"sex":{},"title":"Human and mouse gut microbiome sequencing datasets related to immune checkpoint inhibitor therapy and immune-related adverse events.","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1314234","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1314234_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1314234.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1314234.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1314234.csv.gz"}},{"accession":"PRJNA532645","age_categories":{"adolescent":112,"adult":18,"child":51,"infant":5},"countries":{"CA":4,"FI":1,"IL":120,"IT":15},"first_public_year":"2019","gbp_per_sample_median":0.47,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"ulcerative_colitis":186},"intervention_design":"unknown","intervention_detail":"","interventions":[],"n_samples":186,"papers":[{"doi":"10.1016/j.isci.2024.111442","pmcid":"PMC11650326","pmid":"39691780","title":"Gut-microbiota-based ensemble model predicts prognosis of pediatric inflammatory bowel disease."},{"doi":"10.1016/j.chom.2025.01.002","pmcid":"PMC12268991","pmid":"39947133","title":"A meta-analysis of the gut microbiome in inflammatory bowel disease patients identifies disease-associated small molecules."}],"sample_intervention_arms":{"antibiotic":78,"drug_therapy":108},"sex":{"female":98,"male":88},"title":"PRASCO gut microbiome profile of Pediatric Severe Acute Ulcerative Colitis patients under Antimicrobial treatment","trial_population_condition":"unknown","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA532645","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA532645_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA532645.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA532645.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA532645.csv.gz"}},{"accession":"PRJEB42363","age_categories":{"unknown":181},"countries":{"MW":4,"ZA":177},"first_public_year":"2021","gbp_per_sample_median":2.65,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"randomized_controlled_trial","intervention_detail":"Azithromycin mass drug administration vs placebo in children, 4 rounds","interventions":["antibiotic"],"n_samples":181,"papers":[{"doi":"10.1128/spectrum.00665-23","pmcid":"PMC10269646","pmid":"37191543","title":"Exploring Molecular Interactions between Human Milk Hormone Insulin and Bifidobacteria."},{"doi":"10.1038/s41522-025-00868-7","pmcid":"PMC12769767","pmid":"41350579","title":"Compiling an early life human gut microbiome atlas and identification of key microbial drivers."}],"sample_intervention_arms":{},"sex":{},"title":"Impact of azithromycin mass drug administration on the antibiotic resistant gut microbiome: a randomized, controlled trial","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB42363","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB42363_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB42363.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB42363.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB42363.csv.gz"}},{"accession":"PRJNA549787","age_categories":{"infant":163,"neonate":2},"countries":{"ZA":165},"first_public_year":"2019","gbp_per_sample_median":1.15,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{},"intervention_design":"randomized_controlled_trial","intervention_detail":"Prophylactic cotrimoxazole vs no cotrimoxazole in HEU infants","interventions":["antibiotic"],"n_samples":165,"papers":[{"doi":"10.1093/cid/ciz1186","pmcid":"PMC7778358","pmid":"31832638","title":"Cotrimoxazole Prophylaxis Increases Resistance Gene Prevalence and α-Diversity but Decreases β-Diversity in the Gut Microbiome of Human Immunodeficiency Virus-Exposed, Uninfected Infants."},{"doi":"10.1111/1758-2229.12960","pmcid":"PMC8518733","pmid":"34152069","title":"Investigating the infant gut microbiota in developing countries: worldwide metagenomic meta-analysis involving infants living in sub-urban areas of Côte d'Ivoire."},{"doi":"10.1111/1462-2920.16205","pmcid":"PMC10092070","pmid":"36123315","title":"Designation of optimal reference strains representing the infant gut bifidobacterial species through a comprehensive multi-omics approach."},{"doi":"10.3389/fmicb.2022.1006721","pmcid":"PMC9512645","pmid":"36177457","title":"Gut microbe metabolism of small molecules supports human development across the early stages of life."},{"doi":"10.1038/s41522-022-00349-1","pmcid":"PMC9622858","pmid":"36316342","title":"Exploring species-level infant gut bacterial biodiversity by meta-analysis and formulation of an optimized cultivation medium."}],"sample_intervention_arms":{"antibiotic":92,"no_intervention":73},"sex":{"female":68,"male":89},"title":"South African HIV-exposed, uninfected infant gut microbiomes","trial_population_condition":"unknown","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA549787","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA549787_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA549787.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA549787.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA549787.csv.gz"}},{"accession":"PRJEB28058","age_categories":{"adult":164},"countries":{"DE":164},"first_public_year":"2019","gbp_per_sample_median":11.58,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":164},"intervention_design":"unknown","intervention_detail":"Cotrimoxazole or ciprofloxacin prophylactic antibiotic, samples before/after treatment","interventions":["antibiotic"],"n_samples":164,"papers":[{"doi":"10.1186/s12915-019-0692-y","pmcid":"PMC6749691","pmid":"31533707","title":"Distinct impact of antibiotics on the gut microbiome and resistome: a longitudinal multicenter cohort study."},{"doi":"10.1186/s40168-023-01604-z","pmcid":"PMC10408196","pmid":"37553697","title":"Identification of robust and generalizable biomarkers for microbiome-based stratification in lifestyle interventions."}],"sample_intervention_arms":{},"sex":{},"title":"Impact of antibiotics on the human gut microbiome and resistome","trial_population_condition":"transplant_or_immunocompromised","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB28058","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB28058_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB28058.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB28058.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB28058.csv.gz"}},{"accession":"PRJEB40995","age_categories":{"adult":162},"countries":{"CH":162},"first_public_year":"2021","gbp_per_sample_median":3.28,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"randomized_controlled_trial","intervention_detail":"Antibiotics for 7±2 vs 14±3 days for gram-negative bacteraemia","interventions":["antibiotic"],"n_samples":162,"papers":[{"doi":"10.1016/j.ebiom.2021.103566","pmcid":"PMC8426194","pmid":"34492446","title":"Effects of antibiotic duration on the intestinal microbiota and resistome: The PIRATE RESISTANCE project, a cohort study nested within a randomized trial."}],"sample_intervention_arms":{"no_intervention":21},"sex":{},"title":"Effects of antibiotic duration on the intestinal microbiota and resistome","trial_population_condition":"gi_infection_or_diarrhoea","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB40995","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB40995_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB40995.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB40995.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB40995.csv.gz"}},{"accession":"PRJEB47061","age_categories":{"unknown":160},"countries":{"AT":160},"first_public_year":"2021","gbp_per_sample_median":6.26,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"ulcerative_colitis":122},"intervention_design":"unknown","intervention_detail":"FMT for ulcerative colitis; donor stool transplant","interventions":["antibiotic","bowel_preparation","fmt"],"n_samples":160,"papers":[{"doi":"10.1016/j.xcrm.2022.100711","pmcid":"PMC9418803","pmid":"35931074","title":"Identification of clinical and ecological determinants of strain engraftment after fecal microbiota transplantation using metagenomics."}],"sample_intervention_arms":{"fmt":122,"no_intervention":38},"sex":{},"title":"Fecal microbiota transplantation for treatment of ulcerative colitis","trial_population_condition":"ulcerative_colitis","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB47061","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB47061_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB47061.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB47061.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB47061.csv.gz"}},{"accession":"PRJNA530252","age_categories":{"unknown":157},"countries":{"US":157},"first_public_year":"2020","gbp_per_sample_median":1.01,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_disease":157},"intervention_design":"single_arm_before_after","intervention_detail":"Cycled inhaled tobramycin, one-month maintenance course","interventions":["antibiotic"],"n_samples":157,"papers":[{"doi":"10.1136/thoraxjnl-2019-214187","pmcid":"PMC7875198","pmid":"32631930","title":"Maintenance tobramycin primarily affects untargeted bacteria in the CF sputum microbiome."}],"sample_intervention_arms":{},"sex":{},"title":"Effect of cycled, inhaled tobramycin on the sputum microbiome in cystic fibrosis","trial_population_condition":"other_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA530252","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA530252_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA530252.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA530252.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA530252.csv.gz"}},{"accession":"PRJNA787952","age_categories":{"adolescent":41,"adult":51,"child":54,"unknown":9},"countries":{"US":155},"first_public_year":"2022","gbp_per_sample_median":4.58,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":98,"other_disease":51,"transplant_or_immunocompromised":6},"intervention_design":"randomized_controlled_trial","intervention_detail":"Oral vancomycin-polymyxin B gut decontamination vs no-GD in allo-HCT patients","interventions":["antibiotic"],"n_samples":155,"papers":[{"doi":"10.1172/jci.insight.154344","pmcid":"PMC9057614","pmid":"35239511","title":"Microbiota dynamics in a randomized trial of gut decontamination during allogeneic hematopoietic cell transplantation."},{"doi":"10.1101/2021.12.16.21267940","pmcid":null,"pmid":null,"title":"Randomized controlled trial of gut decontamination in pediatric patients undergoing allogeneic hematopoietic cell transplantation"}],"sample_intervention_arms":{},"sex":{},"title":"Raw_metagenomic_sequencing_for_Pediatrics_Gut_Decontamination_NCT02641236","trial_population_condition":"transplant_or_immunocompromised","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA787952","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA787952_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA787952.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA787952.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA787952.csv.gz"}},{"accession":"PRJEB35816","age_categories":{"adult":152},"countries":{"CH":152},"first_public_year":"2020","gbp_per_sample_median":1.12,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"randomized_controlled_trial","intervention_detail":"Oral colistin/neomycin then FMT vs treatment-naive controls","interventions":["antibiotic","fmt"],"n_samples":152,"papers":[{"doi":"10.3390/microorganisms8060941","pmcid":"PMC7357103","pmid":"32585945","title":"Metagenomic Characterization of Gut Microbiota of Carriers of Extended-Spectrum Beta-Lactamase or Carbapenemase-Producing Enterobacteriaceae Following Treatment with Oral Antibiotics and Fecal Microbi"}],"sample_intervention_arms":{},"sex":{},"title":"Gut microbiota of carriers of extended-spectrum beta-lactamase or carbapenemase-producing Enterobacteriaceae following treatment with oral antibiotics and fecal microbiota transplantation","trial_population_condition":"gi_infection_or_diarrhoea","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB35816","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB35816_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB35816.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB35816.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB35816.csv.gz"}},{"accession":"PRJNA1015704","age_categories":{"infant":140,"unknown":8},"countries":{},"first_public_year":"2025","gbp_per_sample_median":2.95,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_disease":148},"intervention_design":"observational_with_procedure","intervention_detail":"Beta-lactam antibiotics for respiratory exacerbations; sampled on vs off vs never treated","interventions":["antibiotic"],"n_samples":148,"papers":[{"doi":"10.1002/ppul.71024","pmcid":"PMC11881217","pmid":"40042126","title":"Effects of Therapeutic Antibiotic Exposure on the Oropharyngeal and Fecal Microbiota in Infants With Cystic Fibrosis."}],"sample_intervention_arms":{},"sex":{},"title":"Fecal and oropharyngeal microbiota from infants with cystic fibrosis on and off beta-lactam antibiotics.","trial_population_condition":"other_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1015704","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1015704_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1015704.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1015704.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1015704.csv.gz"}},{"accession":"PRJNA656820","age_categories":{"child":148},"countries":{"US":148},"first_public_year":"2021","gbp_per_sample_median":0.43,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":148},"intervention_design":"non_randomized_controlled","intervention_detail":"Levofloxacin antibiotic prophylaxis vs no prophylaxis during leukaemia induction","interventions":["antibiotic"],"n_samples":148,"papers":[{"doi":"10.1016/s2666-5247(20)30202-0","pmcid":"PMC8336918","pmid":"34355208","title":"Antibiotic prophylaxis and the gastrointestinal resistome in paediatric patients with acute lymphoblastic leukaemia: a cohort study with metagenomic sequencing analysis."}],"sample_intervention_arms":{},"sex":{},"title":"Human stool sequencing","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA656820","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA656820_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA656820.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA656820.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA656820.csv.gz"}},{"accession":"PRJNA1129514","age_categories":{"unknown":139},"countries":{"US":139},"first_public_year":"2025","gbp_per_sample_median":10.39,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_disease":139},"intervention_design":"observational_with_procedure","intervention_detail":"Prophylactic/empirical antibiotics during AML induction chemotherapy","interventions":["antibiotic"],"n_samples":139,"papers":[{"doi":"10.3390/antibiotics14080770","pmcid":"PMC12382674","pmid":"40867965","title":"Characterization of Antibiotic Administration Factors Associated with Microbiome Disruption and Subsequent Antibiotic-Resistant Infection and Colonization Events in Acute Myeloid Leukemia Patients Rec"},{"doi":"10.3389/fcimb.2025.1629422","pmcid":"PMC12408608","pmid":"40918253","title":"Utilization of machine learning to predict antibiotic resistant event outcomes in acute myeloid leukemia patients undergoing induction chemotherapy."},{"doi":"10.1080/29933935.2025.2570502","pmcid":"PMC12940128","pmid":"41909910","title":"Gut microbiome features and resistome elements associated with colonization and infection with antibiotic-resistance threats."}],"sample_intervention_arms":{},"sex":{},"title":"Shotgun metagenomics for PA13 AML patients Raw sequence reads Raw sequence reads","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1129514","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1129514_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1129514.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1129514.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1129514.csv.gz"}},{"accession":"PRJNA843681","age_categories":{"unknown":135},"countries":{"CN":135},"first_public_year":"2023","gbp_per_sample_median":0.02,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_disease":135},"intervention_design":"single_arm_before_after","intervention_detail":"H. pylori eradication therapy in FD patients","interventions":["antibiotic"],"n_samples":135,"papers":[{"doi":"10.3389/fmicb.2023.1288920","pmcid":"PMC10663309","pmid":"38029178","title":"Diversity recovery and probiotic shift of gastric microbiota in functional dyspepsia patients after Helicobacter pylori eradication therapy."}],"sample_intervention_arms":{},"sex":{},"title":"gastric mucosa of FD patients","trial_population_condition":"other_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA843681","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA843681_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA843681.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA843681.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA843681.csv.gz"}},{"accession":"PRJEB94155","age_categories":{"child":134},"countries":{"NL":134},"first_public_year":"2026","gbp_per_sample_median":8.99,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"gi_infection_or_diarrhoea":134},"intervention_design":"randomized_controlled_trial","intervention_detail":"Oral amoxicillin suspension vs hydrocortisone-bacitracin-colistin topical eardrops for 7 days","interventions":["antibiotic"],"n_samples":134,"papers":[{"doi":"10.1017/s0950268826101836","pmcid":"PMC13366364","pmid":"42333002","title":"The impact of topical or oral antibiotics in children with acute otitis media on their middle ear, nasopharyngeal, and gut microbiomes."}],"sample_intervention_arms":{},"sex":{},"title":"The impact of topical or oral antibiotics in children with acute otitis media on their middle ear, nasopharyngeal, and gut microbiomes","trial_population_condition":"other_infection","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB94155","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB94155_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB94155.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB94155.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB94155.csv.gz"}},{"accession":"PRJNA1364832","age_categories":{"adult":129},"countries":{"NL":129},"first_public_year":"2026","gbp_per_sample_median":5.1,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":129},"intervention_design":"randomized_controlled_trial","intervention_detail":"Vancomycin pretreatment then NTCD spore capsules vs placebo","interventions":["antibiotic","live_biotherapeutic"],"n_samples":129,"papers":[{"doi":"10.1038/s41467-026-74327-y","pmcid":"PMC13408661","pmid":"42286003","title":"Experimental human colonisation with non-toxigenic Clostridioides difficile: a placebo-controlled randomised clinical trial."}],"sample_intervention_arms":{"live_biotherapeutic":1,"placebo":16},"sex":{},"title":"Gut microbiome profiles following vancomycin pretreatment in an experimental human C. difficile colonisation model","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1364832","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1364832_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1364832.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1364832.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1364832.csv.gz"}},{"accession":"PRJNA1099775","age_categories":{"adult":127},"countries":{"US":127},"first_public_year":"2025","gbp_per_sample_median":0.76,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"randomized_controlled_trial","intervention_detail":"Doxycycline 200mg post-exposure prophylaxis vs standard of care","interventions":["antibiotic"],"n_samples":127,"papers":[{"doi":"10.1038/s41591-024-03274-2","pmcid":"PMC11750720","pmid":"39363100","title":"Impact of doxycycline post-exposure prophylaxis for sexually transmitted infections on the gut microbiome and antimicrobial resistome."}],"sample_intervention_arms":{},"sex":{"male":127},"title":"Doxycycline post-exposure prophylaxis for sexually transmitted infections impacts the gut antimicrobial resistome","trial_population_condition":"other_infection","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1099775","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1099775_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1099775.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1099775.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1099775.csv.gz"}},{"accession":"PRJNA1200790","age_categories":{"adult":126},"countries":{"KR":126},"first_public_year":"2024","gbp_per_sample_median":7.74,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"intervention_cohort":126},"intervention_design":"single_arm_before_after","intervention_detail":"Perioperative prophylactic cefazolin in orthopedic surgery patients, sampled before/after","interventions":["antibiotic","surgery"],"n_samples":126,"papers":[{"doi":"10.3390/antibiotics15070706","pmcid":"PMC13405979","pmid":"42505669","title":"Changes in the Gut Microbiome Following Perioperative Prophylactic Cefazolin Administration in Patients Undergoing Orthopedic Surgery: A Longitudinal Prospective Study."}],"sample_intervention_arms":{},"sex":{},"title":"Effect of cefazolin administration on the gut microbiome in patients undergoing orthopedic surgery","trial_population_condition":"unknown","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1200790","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1200790_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1200790.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1200790.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1200790.csv.gz"}},{"accession":"PRJNA749138","age_categories":{"adult":121},"countries":{"HK":121},"first_public_year":"2022","gbp_per_sample_median":8.0,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"gi_infection_or_diarrhoea":121},"intervention_design":"single_arm_before_after","intervention_detail":"H. pylori eradication antibiotic therapy, sampled before/after","interventions":["antibiotic"],"n_samples":121,"papers":[{"doi":"10.1038/s41467-023-37975-y","pmcid":"PMC10110541","pmid":"37069161","title":"Altered human gut virome in patients undergoing antibiotics therapy for Helicobacter pylori."}],"sample_intervention_arms":{"antibiotic":77,"no_intervention":44},"sex":{"female":73,"male":48},"title":"Homo sapiens Raw sequence reads","trial_population_condition":"gi_infection_or_diarrhoea","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA749138","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA749138_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA749138.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA749138.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA749138.csv.gz"}},{"accession":"PRJNA663786","age_categories":{"unknown":120},"countries":{"IT":40},"first_public_year":"2021","gbp_per_sample_median":0.03,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"observational_with_procedure","intervention_detail":"Amoxicillin-clavulanic acid therapy in children, gut microbiota compared","interventions":["antibiotic"],"n_samples":120,"papers":[{"doi":"10.1128/aem.03137-20","pmcid":"PMC8091617","pmid":"33483308","title":"Amoxicillin-Clavulanic Acid Resistance in the Genus Bifidobacterium."}],"sample_intervention_arms":{},"sex":{},"title":"Unveiling the bifidobacterial resistance mechanism against amoxicillin-clavulanic acid: genetic and ecological insights","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA663786","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA663786_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA663786.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA663786.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA663786.csv.gz"}},{"accession":"PRJDB14272","age_categories":{"unknown":114},"countries":{"JP":114},"first_public_year":"2026","gbp_per_sample_median":0.16,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"ulcerative_colitis":114},"intervention_design":"single_arm_before_after","intervention_detail":"Antibiotic combination therapy for ulcerative colitis","interventions":["antibiotic"],"n_samples":114,"papers":[],"sample_intervention_arms":{},"sex":{},"title":"Metagenomic analysis of fecal samples obtained from ulcerative colitis patient in Japan","trial_population_condition":"ulcerative_colitis","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJDB14272","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJDB14272_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJDB14272.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJDB14272.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJDB14272.csv.gz"}},{"accession":"PRJNA745170","age_categories":{"child":31,"infant":79},"countries":{"US":110},"first_public_year":"2022","gbp_per_sample_median":5.23,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"gi_infection_or_diarrhoea":110},"intervention_design":"randomized_controlled_trial","intervention_detail":"5-day vs 10-day beta-lactam therapy for pneumonia","interventions":["antibiotic"],"n_samples":110,"papers":[{"doi":"10.1093/infdis/jiac082","pmcid":"PMC9492313","pmid":"35249113","title":"Gastrointestinal Microbiome Disruption and Antibiotic-Associated Diarrhea in Children Receiving Antibiotic Therapy for Community-Acquired Pneumonia."}],"sample_intervention_arms":{},"sex":{"female":53,"male":57},"title":"Gut microbiota in children receiving a strategy of short course vs standard treatment for community acquired pneumonia","trial_population_condition":"gi_infection_or_diarrhoea","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA745170","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA745170_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA745170.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA745170.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA745170.csv.gz"}},{"accession":"PRJNA338184","age_categories":{"adult":109},"countries":{"US":109},"first_public_year":"2016","gbp_per_sample_median":14.95,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"gi_infection_or_diarrhoea":109},"intervention_design":"unknown","intervention_detail":"Enterotoxigenic E. coli human challenge study","interventions":["other_intervention"],"n_samples":109,"papers":[{"doi":"10.1038/s41598-021-94911-0","pmcid":"PMC8342411","pmid":"34354114","title":"Evaluation of a high-throughput, cost-effective Illumina library preparation kit."},{"doi":"10.1093/nar/gkaf1205","pmcid":"PMC12807719","pmid":"41359024","title":"gutMSNP: a comprehensive database for human gut microbial single-nucleotide polymorphisms."}],"sample_intervention_arms":{"antibiotic":42},"sex":{},"title":"Human gut microbiome with bacterial pathogen challenge","trial_population_condition":"gi_infection_or_diarrhoea","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA338184","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA338184_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA338184.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA338184.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA338184.csv.gz"}},{"accession":"PRJEB85867","age_categories":{"adult":108},"countries":{"NL":108},"first_public_year":"2026","gbp_per_sample_median":10.66,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{},"intervention_design":"randomized_controlled_trial","intervention_detail":"Narrow- or broad-spectrum antibiotics vs untreated controls","interventions":["antibiotic"],"n_samples":108,"papers":[],"sample_intervention_arms":{"antibiotic":29,"no_intervention":39},"sex":{},"title":"Narrow- and broad-spectrum antibiotics treatment dramatically alters the intestinal bacterial, viral and metabolomic composition of healthy volunteers","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB85867","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB85867_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB85867.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB85867.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB85867.csv.gz"}},{"accession":"PRJEB35769","age_categories":{"adult":107},"countries":{"DE":107},"first_public_year":"2020","gbp_per_sample_median":8.86,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":107},"intervention_design":"randomized_controlled_trial","intervention_detail":"Multi-strain fermented milk (L. paracasei CNCM I-1518/I-3689, L. rhamnosus CNCM I-3690 + yogurt strains) vs control, with H. pylori eradication","interventions":["antibiotic","probiotic"],"n_samples":107,"papers":[{"doi":"10.1038/s41598-020-72161-w","pmcid":"PMC7524715","pmid":"32994487","title":"Safety and functional enrichment of gut microbiome in healthy subjects consuming a multi-strain fermented milk product: a randomised controlled trial."},{"doi":"10.1080/19490976.2022.2094664","pmcid":"PMC9348039","pmid":"35916669","title":"Improved gut microbiome recovery following drug therapy is linked to abundance and replication of probiotic strains."}],"sample_intervention_arms":{},"sex":{},"title":"Gut microbiome response to a fermented milk product in healthy subjects","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB35769","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB35769_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB35769.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB35769.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB35769.csv.gz"}},{"accession":"PRJNA1135945","age_categories":{"unknown":104},"countries":{"CN":104},"first_public_year":"2025","gbp_per_sample_median":12.28,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_disease":104},"intervention_design":"randomized_controlled_trial","intervention_detail":"Rifaximin (gut-specific antibiotic) vs standard care in predicted SAP patients","interventions":["antibiotic"],"n_samples":104,"papers":[{"doi":"10.1128/spectrum.01299-25","pmcid":"PMC12502533","pmid":"40919785","title":"Rifaximin reduces gut-derived inflammation in severe acute pancreatitis: an experimental animal model and randomized controlled trial."},{"doi":"10.1080/19490976.2025.2606480","pmcid":"PMC12758309","pmid":"41439481","title":"Gut microbiota dysbiosis exacerbates acute pancreatitis via <i>Escherichia coli</i>-driven neutrophil heterogeneity and NETosis."}],"sample_intervention_arms":{},"sex":{},"title":"Rifaximin reduces gut-derived inflammation in severe acute pancreatitis","trial_population_condition":"other_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1135945","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1135945_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1135945.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1135945.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1135945.csv.gz"}},{"accession":"PRJNA978931","age_categories":{"adult":101},"countries":{"US":101},"first_public_year":"2024","gbp_per_sample_median":21.61,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":101},"intervention_design":"randomized_controlled_trial","intervention_detail":"SER-401 spore formulation + vancomycin preconditioning + nivolumab vs placebo, melanoma","interventions":["antibiotic","drug_therapy","live_biotherapeutic"],"n_samples":101,"papers":[{"doi":"10.1158/2159-8290.cd-24-0066","pmcid":"PMC11215408","pmid":"38588588","title":"Randomized Placebo-Controlled, Biomarker-Stratified Phase Ib Microbiome Modulation in Melanoma: Impact of Antibiotic Preconditioning on Microbiome and Immunity."}],"sample_intervention_arms":{},"sex":{},"title":"Microbiome intervention with SER-401 prior to nivolumab for unresectable or metastatic melanoma: a randomized placebo-controlled, biomarker-stratified multicenter phase 1b trial","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA978931","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA978931_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA978931.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA978931.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA978931.csv.gz"}},{"accession":"PRJNA1002577","age_categories":{"adult":100},"countries":{"ML":100},"first_public_year":"2023","gbp_per_sample_median":6.01,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"single_arm_before_after","intervention_detail":"First-line anti-tuberculosis antibiotic treatment, sampled before/during/after treatment","interventions":["antibiotic"],"n_samples":100,"papers":[{"doi":"10.3389/fimmu.2025.1561459","pmcid":"PMC12116645","pmid":"40438118","title":"Metabolic and immune consequences of antibiotic related microbiome alterations during first-line tuberculosis treatment in Bamako, Mali."},{"doi":"10.64898/2025.12.04.691125","pmcid":null,"pmid":null,"title":"MetaPointFinder: Detection of Antimicrobial Resistance-Conferring Point Mutations (ARMs) from Metagenomic Reads"}],"sample_intervention_arms":{},"sex":{},"title":"Antibiotic Related Microbiome Alterations during first-line Tuberculosis Treatment in Bamako, Mali","trial_population_condition":"other_infection","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1002577","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1002577_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1002577.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1002577.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1002577.csv.gz"}},{"accession":"PRJEB22175","age_categories":{"adult":96},"countries":{"GB":96},"first_public_year":"2019","gbp_per_sample_median":2.18,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"gi_infection_or_diarrhoea":96},"intervention_design":"single_arm_before_after","intervention_detail":"Human challenge with S. Typhi/Paratyphi A, then antibiotic treatment","interventions":["antibiotic","other_intervention"],"n_samples":96,"papers":[{"doi":"10.1186/s40168-025-02125-7","pmcid":"PMC12281769","pmid":"40696437","title":"Interplay between the gut microbiome and typhoid fever: insights from endemic countries and a controlled human infection model."},{"doi":"10.1101/2024.09.02.24312347","pmcid":null,"pmid":null,"title":"Interplay Between the Gut Microbiome and Typhoid Fever: Insights from Endemic Countries and a Controlled Human Infection Model"}],"sample_intervention_arms":{},"sex":{},"title":"PATCH_MICROBIOME","trial_population_condition":"gi_infection_or_diarrhoea","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB22175","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB22175_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB22175.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB22175.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB22175.csv.gz"}},{"accession":"PRJEB39128","age_categories":{"child":96},"countries":{"AU":96},"first_public_year":"2022","gbp_per_sample_median":6.65,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_infection":96},"intervention_design":"randomized_controlled_trial","intervention_detail":"IV ceftriaxone at home vs IV flucloxacillin in hospital for cellulitis","interventions":["antibiotic"],"n_samples":96,"papers":[],"sample_intervention_arms":{},"sex":{},"title":"Comparison of two antibiotic treatments on the microbiome and resistome in children who presented to the ED with moderate/severe cellulitis","trial_population_condition":"other_infection","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB39128","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB39128_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB39128.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB39128.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB39128.csv.gz"}},{"accession":"PRJNA589622","age_categories":{"adult":95},"countries":{"US":95},"first_public_year":"2019","gbp_per_sample_median":3.38,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{},"intervention_design":"randomized_controlled_trial","intervention_detail":"Underfeeding vs overfeeding diet; oral vancomycin vs placebo","interventions":["antibiotic","diet_intervention"],"n_samples":95,"papers":[{"doi":"10.3390/ijms22073652","pmcid":"PMC8038126","pmid":"33915727","title":"Diet-Related Alterations of Gut Bile Salt Hydrolases Determined Using a Metagenomic Analysis of the Human Microbiome."}],"sample_intervention_arms":{"diet_intervention":38,"no_intervention":57},"sex":{},"title":"Underfeeding and oral vancomycin perturb the human gut microbiome and impair nutrient absorption","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA589622","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA589622_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA589622.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA589622.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA589622.csv.gz"}},{"accession":"PRJNA1055141","age_categories":{"infant":48,"neonate":46},"countries":{"CA":94},"first_public_year":"2023","gbp_per_sample_median":0.64,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"single_arm_before_after","intervention_detail":"Antibiotic treatment in infants, sampled before and after","interventions":["antibiotic"],"n_samples":94,"papers":[{"doi":"10.1038/s41467-026-74417-x","pmcid":"PMC13291269","pmid":"42336834","title":"Antibiotic-induced Malassezia expansion in the infant gut promotes early-life immune dysregulation and airway inflammation in mice."}],"sample_intervention_arms":{"antibiotic":1},"sex":{"female":32,"male":62},"title":"Infant stool shallow shotgun sequencing (ANTIBIO)","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1055141","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1055141_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1055141.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1055141.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1055141.csv.gz"}},{"accession":"PRJNA1191223","age_categories":{"infant":92},"countries":{"GB":92},"first_public_year":"2025","gbp_per_sample_median":1.41,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{},"intervention_design":"observational_with_procedure","intervention_detail":"Probiotic (Bifidobacterium) cohort vs non-probiotic; antibiotics benzylpenicillin/gentamicin in some infants","interventions":["antibiotic","probiotic"],"n_samples":92,"papers":[{"doi":"10.1038/s41467-025-62584-2","pmcid":"PMC12354744","pmid":"40813371","title":"Impact of early life antibiotic and probiotic treatment on gut microbiome and resistome of very-low-birth-weight preterm infants."}],"sample_intervention_arms":{"no_intervention":53,"probiotic":39},"sex":{},"title":"Impact of early life antibiotic and probiotic treatment on gut microbiome and resistome of preterm infants (metagenome samples)","trial_population_condition":"preterm_nicu","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1191223","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1191223_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1191223.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1191223.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1191223.csv.gz"}},{"accession":"PRJNA413659","age_categories":{"adult":81,"elderly":11},"countries":{"RU":92},"first_public_year":"2017","gbp_per_sample_median":1.42,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"gi_infection_or_diarrhoea":92},"intervention_design":"single_arm_before_after","intervention_detail":"Quadruple HP eradication: amoxicillin, clarithromycin, PPI, bismuth subsalicylate","interventions":["antibiotic","drug_therapy"],"n_samples":92,"papers":[{"doi":"10.3389/fmicb.2019.01902","pmcid":"PMC6718723","pmid":"31507546","title":"Shifts in the Human Gut Microbiota Structure Caused by Quadruple Helicobacter pylori Eradication Therapy."}],"sample_intervention_arms":{},"sex":{"female":46,"male":46},"title":"Shifts of the intestinal microbiota and resistome caused by Helicobacter pylori eradication therapy","trial_population_condition":"gi_infection_or_diarrhoea","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA413659","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA413659_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA413659.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA413659.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA413659.csv.gz"}},{"accession":"PRJNA445968","age_categories":{"adolescent":11,"adult":77,"child":3,"elderly":1},"countries":{"HT":92},"first_public_year":"2018","gbp_per_sample_median":0.69,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":29},"intervention_design":"single_arm_before_after","intervention_detail":"Multidrug anti-TB antibiotic therapy (6 months standard regimen, or short-course monotherapy) with pre/post sampling","interventions":["antibiotic"],"n_samples":92,"papers":[{"doi":"10.1038/s41598-017-10346-6","pmcid":"PMC5589918","pmid":"28883399","title":"Antibiotic treatment for Tuberculosis induces a profound dysbiosis of the microbiome that persists long after therapy is completed."},{"doi":"10.1172/jci.insight.121899","pmcid":"PMC6237486","pmid":"30282828","title":"Mucosal-associated invariant and γδ T cell subsets respond to initial Mycobacterium tuberculosis infection."},{"doi":"10.1038/s41467-021-21475-y","pmcid":"PMC7892575","pmid":"33602926","title":"Gastrointestinal microbiota composition predicts peripheral inflammatory state during treatment of human tuberculosis."},{"doi":"10.3390/cells10102704","pmcid":"PMC8534371","pmid":"34685683","title":"Transcriptomic Biomarkers for Tuberculosis: Validation of NPC2 as a Single mRNA Biomarker to Diagnose TB, Predict Disease Progression, and Monitor Treatment Response."}],"sample_intervention_arms":{},"sex":{"female":54,"male":38},"title":"Innate, Transcriptomic, and Microbiomic Correlates of Tuberculosis Infection and Disease","trial_population_condition":"other_infection","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA445968","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA445968_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA445968.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA445968.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA445968.csv.gz"}},{"accession":"PRJNA914532","age_categories":{"adolescent":36,"adult":9,"child":30,"infant":15},"countries":{"IT":90},"first_public_year":"2022","gbp_per_sample_median":2.35,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"transplant_or_immunocompromised":90},"intervention_design":"observational_with_procedure","intervention_detail":"Levofloxacin prophylaxis plus parenteral or enteral nutrition in HSCT","interventions":["antibiotic","diet_intervention"],"n_samples":90,"papers":[{"doi":"10.1038/s42003-023-04436-7","pmcid":"PMC9839701","pmid":"36639555","title":"Levofloxacin prophylaxis and parenteral nutrition have a detrimental effect on intestinal microbial networks in pediatric patients undergoing HSCT."}],"sample_intervention_arms":{},"sex":{},"title":"Levofloxacin prophylaxis and parenteral nutrition have a detrimental effect on intestinal microbial networks in pediatric patients undergoing HSCT","trial_population_condition":"transplant_or_immunocompromised","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA914532","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA914532_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA914532.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA914532.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA914532.csv.gz"}},{"accession":"PRJEB44214","age_categories":{"adult":88},"countries":{"CH":88},"first_public_year":"2022","gbp_per_sample_median":0.09,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"colorectal_cancer":88},"intervention_design":"observational_with_procedure","intervention_detail":"Elective colon cancer surgery; antibiotic prophylaxis (cefuroxime/metronidazole vs carbapenems)","interventions":["antibiotic","surgery"],"n_samples":88,"papers":[{"doi":"10.1186/s13099-021-00477-7","pmcid":"PMC8729125","pmid":"34983654","title":"Changes in the gut bacterial communities in colon cancer surgery patients: an observational study."}],"sample_intervention_arms":{},"sex":{},"title":"Changes in the gut microbiome in colon cancer surgery patients: a pilot observational study","trial_population_condition":"colorectal_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB44214","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB44214_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB44214.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB44214.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB44214.csv.gz"}},{"accession":"PRJNA1004858","age_categories":{"adult":88},"countries":{"CN":88},"first_public_year":"2026","gbp_per_sample_median":6.49,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":60},"intervention_design":"observational_with_procedure","intervention_detail":"Human fecal metagenomics cross-sectional; mouse FMT from clinical donors into antibiotic-treated mice","interventions":["antibiotic"],"n_samples":88,"papers":[{"doi":"10.1080/19490976.2026.2630561","pmcid":"PMC12915779","pmid":"41698880","title":"HLA-B27-associated gut microbiota and amino acid perturbations promote ankylosing spondylitis through M1 macrophage activation."}],"sample_intervention_arms":{},"sex":{},"title":"Metagenome AS and Gut microbiota","trial_population_condition":"autoimmune_inflammatory","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1004858","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1004858_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1004858.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1004858.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1004858.csv.gz"}},{"accession":"PRJNA894204","age_categories":{"adult":85},"countries":{"NO":85},"first_public_year":"2022","gbp_per_sample_median":5.0,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_disease":85},"intervention_design":"randomized_controlled_trial","intervention_detail":"3-month amoxicillin vs placebo for chronic low back pain","interventions":["antibiotic"],"n_samples":85,"papers":[{"doi":"10.1080/19490976.2022.2157200","pmcid":"PMC9809947","pmid":"36576106","title":"Differential response to prolonged amoxicillin treatment: long-term resilience of the microbiome versus long-lasting perturbations in the gut resistome."}],"sample_intervention_arms":{},"sex":{},"title":"Impact of prolonged amoxicillin treatment in the gut microbiome and resistome in patients with low back pain and Modic changes","trial_population_condition":"other_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA894204","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA894204_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA894204.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA894204.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA894204.csv.gz"}},{"accession":"PRJNA353598","age_categories":{"adult":10,"elderly":8,"unknown":65},"countries":{},"first_public_year":"2017","gbp_per_sample_median":6.74,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"gi_infection_or_diarrhoea":24,"healthy_control":20},"intervention_design":"non_randomized_controlled","intervention_detail":"FMT vs vancomycin for recurrent C. difficile infection","interventions":["antibiotic","fmt"],"n_samples":83,"papers":[{"doi":"10.1136/gutjnl-2017-313952","pmcid":"PMC5868238","pmid":"28539351","title":"Bacteriophage transfer during faecal microbiota transplantation in <i>Clostridium difficile</i> infection is associated with treatment outcome."}],"sample_intervention_arms":{"fmt":1},"sex":{"female":11,"male":7},"title":"viral metagenome Metagenome","trial_population_condition":"gi_infection_or_diarrhoea","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA353598","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA353598_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA353598.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA353598.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA353598.csv.gz"}},{"accession":"PRJNA646752","age_categories":{"adult":82},"countries":{"US":82},"first_public_year":"2020","gbp_per_sample_median":0.95,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"gi_infection_or_diarrhoea":82},"intervention_design":"randomized_controlled_trial","intervention_detail":"Oral vancomycin vs placebo in C. difficile-colonized patients","interventions":["antibiotic"],"n_samples":82,"papers":[{"doi":"10.1128/msphere.00936-20","pmcid":"PMC7845614","pmid":"33441409","title":"Randomized Controlled Trial of Oral Vancomycin Treatment in Clostridioides difficile-Colonized Patients."},{"doi":"10.1139/cjm-2025-0288","pmcid":"PMC13177613","pmid":"41875899","title":"Pangenome-GWAS analysis of <i>Clostridioides difficile</i> resistant traits from healthcare- and non-healthcare-associated settings."}],"sample_intervention_arms":{},"sex":{},"title":"C. difficile-colonized patients","trial_population_condition":"gi_infection_or_diarrhoea","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA646752","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA646752_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA646752.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA646752.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA646752.csv.gz"}},{"accession":"PRJEB48897","age_categories":{"adult":76},"countries":{"DK":76},"first_public_year":"2022","gbp_per_sample_median":11.06,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_infection":76},"intervention_design":"observational_with_procedure","intervention_detail":"Broad-spectrum (meropenem/piperacillin-tazobactam) vs narrow-spectrum antibiotics in NICU patients","interventions":["antibiotic"],"n_samples":76,"papers":[{"doi":"10.3390/microorganisms9122542","pmcid":"PMC8703874","pmid":"34946144","title":"Microbiome Compositions and Resistome Levels after Antibiotic Treatment of Critically Ill Patients: An Observational Cohort Study."}],"sample_intervention_arms":{},"sex":{},"title":"Microbiome compositions and resistome levels after antibiotic treatment of critically ill patients – An observational cohort study","trial_population_condition":"unknown","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB48897","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB48897_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB48897.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB48897.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB48897.csv.gz"}},{"accession":"PRJEB112905","age_categories":{"unknown":74},"countries":{"CA":28,"US":46},"first_public_year":"2026","gbp_per_sample_median":5.99,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"gi_infection_or_diarrhoea":74},"intervention_design":"randomized_controlled_trial","intervention_detail":"CRS3123 (200mg or 400mg BID) vs vancomycin for C. difficile infection","interventions":["antibiotic"],"n_samples":74,"papers":[{"doi":"10.1016/s1473-3099(25)00721-2","pmcid":"PMC12937067","pmid":"41581516","title":"Safety and efficacy of CRS3123 in adults with a primary episode or first recurrence of Clostridioides difficile infection: a phase 2, randomised, double-blind, multicentre, vancomycin-controlled study"}],"sample_intervention_arms":{"antibiotic":37,"no_intervention":37},"sex":{},"title":"CRS3123 vs Vancomycin Treatment of CDI Phase II Clinical Trial","trial_population_condition":"gi_infection_or_diarrhoea","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB112905","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB112905_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB112905.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB112905.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB112905.csv.gz"}},{"accession":"PRJNA624223","age_categories":{"adult":55,"elderly":18},"countries":{"CN":70,"HK":3},"first_public_year":"2020","gbp_per_sample_median":3.5,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":15,"other_infection":57},"intervention_design":"observational_with_procedure","intervention_detail":"Empirical antibiotics received by COVID-19 patients (observed, not trial-assigned)","interventions":["antibiotic"],"n_samples":73,"papers":[{"doi":"10.1053/j.gastro.2020.05.048","pmcid":"PMC7237927","pmid":"32442562","title":"Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization."},{"doi":"10.1371/journal.pone.0248730","pmcid":"PMC7963026","pmid":"33725024","title":"Variability in digestive and respiratory tract Ace2 expression is associated with the microbiome."},{"doi":"10.1177/1177932221999428","pmcid":"PMC7961713","pmid":"33786001","title":"Metagenomics Approaches to Investigate the Gut Microbiome of COVID-19 Patients."},{"doi":"10.3389/fcimb.2021.790422","pmcid":"PMC8653907","pmid":"34900762","title":"Alterations in the Composition of Intestinal DNA Virome in Patients With COVID-19."},{"doi":"10.1016/j.ijheh.2021.113882","pmcid":"PMC8664710","pmid":"34915282","title":"Alterations of fecal antibiotic resistome in COVID-19 patients after empirical antibiotic exposure."}],"sample_intervention_arms":{},"sex":{"female":34,"male":39},"title":"Gut microbiome alterations and longitudinal kinetics in COVID-19 patients","trial_population_condition":"other_infection","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA624223","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA624223_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA624223.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA624223.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA624223.csv.gz"}},{"accession":"PRJEB8094","age_categories":{"adult":72},"countries":{"CA":72},"first_public_year":"2015","gbp_per_sample_median":13.55,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"healthy_control":72},"intervention_design":"single_arm_before_after","intervention_detail":"Cefprozil (second-generation cephalosporin), 7-day course, healthy volunteers","interventions":["antibiotic"],"n_samples":72,"papers":[{"doi":"10.1038/ismej.2015.148","pmcid":"PMC4817689","pmid":"26359913","title":"The initial state of the human gut microbiome determines its reshaping by antibiotics."},{"doi":"10.1080/19490976.2016.1216747","pmcid":"PMC5154369","pmid":"27494088","title":"Partial recovery of microbiomes after antibiotic treatment."},{"doi":"10.1186/s40168-019-0657-y","pmcid":"PMC6425642","pmid":"30890181","title":"Mining, analyzing, and integrating viral signals from metagenomic data."},{"doi":"10.1186/s40168-019-0669-7","pmcid":"PMC6451232","pmid":"30953542","title":"Culture-enriched human gut microbiomes reveal core and accessory resistance genes."},{"doi":"10.1016/j.gpb.2018.12.003","pmcid":"PMC6520913","pmid":"31026582","title":"Antibiotic Treatment Drives the Diversification of the Human Gut Resistome."}],"sample_intervention_arms":{"antibiotic":48,"no_intervention":24},"sex":{"female":39,"male":33},"title":"The initial state of the human gut microbiome determines its reshaping by antibiotics","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB8094","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB8094_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB8094.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB8094.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB8094.csv.gz"}},{"accession":"PRJEB8347","age_categories":{"adult":70},"countries":{"DE":70},"first_public_year":"2015","gbp_per_sample_median":5.43,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"single_arm_before_after","intervention_detail":"Antibiotic treatment and bowel cleansing in one subject","interventions":["antibiotic","bowel_preparation"],"n_samples":70,"papers":[{"doi":"10.1186/s13059-015-0639-8","pmcid":"PMC4416267","pmid":"25888008","title":"Temporal and technical variability of human gut metagenomes."},{"doi":"10.1038/nature24628","pmcid":"PMC6070150","pmid":"29143823","title":"Salt-responsive gut commensal modulates T<sub>H</sub>17 axis and disease."},{"doi":"10.1128/msystems.00018-22","pmcid":"PMC9040882","pmid":"35311577","title":"Surgical Treatment for Colorectal Cancer Partially Restores Gut Microbiome and Metabolome Traits."},{"doi":"10.15252/msb.20177589","pmcid":"PMC5740502","pmid":"29242367","title":"Subspecies in the global human gut microbiome."},{"doi":"10.1038/s41522-018-0065-2","pmcid":"PMC6123480","pmid":"30210803","title":"GePMI: A statistical model for personal intestinal microbiome identification."}],"sample_intervention_arms":{},"sex":{"female":8,"male":62},"title":"Temporal and technical variability of human gut metagenomes","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB8347","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB8347_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB8347.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB8347.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB8347.csv.gz"}},{"accession":"PRJNA1063508","age_categories":{"adult":66},"countries":{"RU":66},"first_public_year":"2024","gbp_per_sample_median":2.22,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_infection":66},"intervention_design":"randomized_controlled_trial","intervention_detail":"H. pylori eradication: esomeprazole, clarithromycin, amoxicillin, bismuth +/- butyric acid+inulin (Zacofalk)","interventions":["antibiotic","drug_therapy"],"n_samples":66,"papers":[{"doi":"10.3390/microorganisms12020319","pmcid":"PMC10892928","pmid":"38399723","title":"Butyric Acid Supplementation Reduces Changes in the Taxonomic and Functional Composition of Gut Microbiota Caused by H. pylori Eradication Therapy."}],"sample_intervention_arms":{"drug_therapy":33},"sex":{},"title":"Gut microbiota after H. pylori eradication therapy","trial_population_condition":"gi_infection_or_diarrhoea","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1063508","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1063508_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1063508.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1063508.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1063508.csv.gz"}},{"accession":"PRJNA1445352","age_categories":{"child":62},"countries":{"US":62},"first_public_year":"2026","gbp_per_sample_median":3.13,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"malnutrition":17,"neurological_psychiatric":45},"intervention_design":"randomized_controlled_trial","intervention_detail":"Microbiota transplant therapy with antibiotics and bowel cleansing pretreatment, RCT vs placebo","interventions":["antibiotic","bowel_preparation","fmt"],"n_samples":62,"papers":[{"doi":"10.21203/rs.3.rs-9930475/v1","pmcid":null,"pmid":null,"title":"Microbiota Transplant Therapy (MTT) Improves Gastrointestinal Symptoms in Children with Pitt-Hopkins Syndrome: A Randomized Clinical Trial"}],"sample_intervention_arms":{"antibiotic":12,"fmt":15,"no_intervention":29,"placebo":6},"sex":{},"title":"Microbiota Transplant Therapy (MTT) Improves Gastrointestinal Symptoms by Modulating Gut Microbiota in Children with Pitt-Hopkins Syndrome, A Rare Neurodevelopmental Disorder","trial_population_condition":"neurological_psychiatric","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1445352","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1445352_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1445352.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1445352.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1445352.csv.gz"}},{"accession":"PRJNA1138254","age_categories":{"adult":5,"elderly":55},"countries":{"GB":60},"first_public_year":"2024","gbp_per_sample_median":2.08,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"ibd_unspecified":60},"intervention_design":"single_arm_before_after","intervention_detail":"Oral vancomycin 125mg QID for 4 weeks","interventions":["antibiotic"],"n_samples":60,"papers":[{"doi":"10.1093/ecco-jcc/jjae189","pmcid":"PMC11831226","pmid":"39673746","title":"Open Label Vancomycin in Primary Sclerosing Cholangitis-Inflammatory Bowel Disease: Improved Colonic Disease Activity and Associations With Changes in Host-Microbiome-Metabolomic Signatures."}],"sample_intervention_arms":{},"sex":{},"title":"PSC-Vanc Clinical Trial","trial_population_condition":"unknown","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1138254","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1138254_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1138254.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1138254.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1138254.csv.gz"}},{"accession":"PRJDB20343","age_categories":{"adult":15,"elderly":44},"countries":{"JP":59},"first_public_year":"2025","gbp_per_sample_median":6.74,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"colorectal_cancer":59},"intervention_design":"single_arm_before_after","intervention_detail":"Antibiotic prophylaxis before/after colon cancer surgery","interventions":["antibiotic","surgery"],"n_samples":59,"papers":[{"doi":"10.1016/j.jgar.2025.12.014","pmcid":null,"pmid":"41455576","title":"Impact of antimicrobial prophylaxis in colorectal cancer surgery on the gut and oral microbiome and resistome: A prospective observational cohort study."}],"sample_intervention_arms":{"no_intervention":16},"sex":{"female":22,"male":37},"title":"Shotgun metagenome sequencing of oral and stool samples from colorectal cancer patients before and after administration of antibiotic prophylaxis for surgery","trial_population_condition":"colorectal_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJDB20343","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJDB20343_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJDB20343.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJDB20343.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJDB20343.csv.gz"}},{"accession":"PRJNA588313","age_categories":{"adult":59},"countries":{"DK":59},"first_public_year":"2019","gbp_per_sample_median":11.36,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":59},"intervention_design":"single_arm_before_after","intervention_detail":"Broad-spectrum antibiotic administration to healthy adults, gut microbiome sampled over time","interventions":["antibiotic"],"n_samples":59,"papers":[{"doi":"10.1080/19490976.2021.1900995","pmcid":"PMC8018486","pmid":"33779498","title":"Expansion and persistence of antibiotic-specific resistance genes following antibiotic treatment."},{"doi":"10.1093/nar/gkaa869","pmcid":"PMC7778953","pmid":"33074335","title":"mMGE: a database for human metagenomic extrachromosomal mobile genetic elements."},{"doi":"10.3390/nu15183925","pmcid":"PMC10536327","pmid":"37764709","title":"Uncovering Predictive Factors and Interventions for Restoring Microecological Diversity after Antibiotic Disturbance."}],"sample_intervention_arms":{},"sex":{},"title":"Human gut microbiome and virome under antibiotic treatment Raw sequence reads","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA588313","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA588313_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA588313.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA588313.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA588313.csv.gz"}},{"accession":"PRJEB20800","age_categories":{"adult":57},"countries":{"DK":57},"first_public_year":"2018","gbp_per_sample_median":6.57,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"healthy_control":57},"intervention_design":"single_arm_before_after","intervention_detail":"4-day broad-spectrum triple antibiotic intervention (meropenem, vancomycin, gentamicin)","interventions":["antibiotic"],"n_samples":57,"papers":[{"doi":"10.3389/fmicb.2020.01376","pmcid":"PMC7338343","pmid":"32695079","title":"Mobilization of Antibiotic Resistance: Are Current Approaches for Colocalizing Resistomes and Mobilomes Useful?"},{"doi":"10.1038/s41522-019-0103-8","pmcid":"PMC6789009","pmid":"31632686","title":"Individualized recovery of gut microbial strains post antibiotics."},{"doi":"10.1126/sciadv.aaz2299","pmcid":"PMC7176420","pmid":"32494636","title":"Metagenomic growth rate inferences of strains in situ."},{"doi":"10.1016/j.chom.2021.05.008","pmcid":"PMC8288446","pmid":"34111423","title":"Dispersal strategies shape persistence and evolution of human gut bacteria."},{"doi":"10.1080/19490976.2022.2135963","pmcid":"PMC9621045","pmid":"36289064","title":"Functional profile of host microbiome indicates Clostridioides difficile infection."}],"sample_intervention_arms":{"antibiotic":45,"no_intervention":12},"sex":{"male":57},"title":"Gut resistome modulates resilience and recovery of gut microbiota after broad-spectrum antibiotic treatment","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB20800","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB20800_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB20800.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB20800.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB20800.csv.gz"}},{"accession":"PRJEB108131","age_categories":{"adult":54},"countries":{"NL":54},"first_public_year":"2026","gbp_per_sample_median":1.26,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{},"intervention_design":"randomized_controlled_trial","intervention_detail":"Vancomycin 7 days, then randomised to 2'-FL prebiotic vs placebo","interventions":["antibiotic","prebiotic_or_fibre"],"n_samples":54,"papers":[],"sample_intervention_arms":{"placebo":27,"prebiotic_or_fibre":27},"sex":{"female":30,"male":24},"title":"CARMA: Human gut long read metagenomics antibiotics and prebiotics RCT","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB108131","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB108131_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB108131.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB108131.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB108131.csv.gz"}},{"accession":"PRJNA1512161","age_categories":{"adult":54},"countries":{"ES":54},"first_public_year":"2026","gbp_per_sample_median":5.28,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{},"intervention_design":"randomized_controlled_trial","intervention_detail":"FMT (EUTEGRA/MBK-01) vs fidaxomicin for recurrent C. difficile infection","interventions":["antibiotic","fmt"],"n_samples":54,"papers":[],"sample_intervention_arms":{"antibiotic":15,"fmt":12,"no_intervention":27},"sex":{},"title":"Fecal Microbiota Transplantation Achieves Greater Restoration of Microbiota Diversity and Higher Butyrate Production than Fidaxomicin","trial_population_condition":"gi_infection_or_diarrhoea","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1512161","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1512161_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1512161.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1512161.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1512161.csv.gz"}},{"accession":"PRJEB48983","age_categories":{"adult":53},"countries":{"LV":53},"first_public_year":"2022","gbp_per_sample_median":5.46,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"gi_infection_or_diarrhoea":53},"intervention_design":"single_arm_before_after","intervention_detail":"H. pylori eradication therapy, pre- vs post-treatment fecal samples","interventions":["antibiotic"],"n_samples":53,"papers":[{"doi":"10.1371/journal.pone.0289879","pmcid":"PMC10414638","pmid":"37561723","title":"Abundance and prevalence of ESBL coding genes in patients undergoing first line eradication therapy for Helicobacter pylori."}],"sample_intervention_arms":{},"sex":{},"title":"Targeted and shotgun analysis on ESBL abundance in the human gut microbiome","trial_population_condition":"unknown","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB48983","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB48983_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB48983.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB48983.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB48983.csv.gz"}},{"accession":"PRJEB97980","age_categories":{"adult":52},"countries":{"DE":52},"first_public_year":"2026","gbp_per_sample_median":26.42,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"observational_with_procedure","intervention_detail":"Doxycycline antimalarial chemoprophylaxis in deployed soldiers","interventions":["antibiotic"],"n_samples":52,"papers":[{"doi":"10.1016/j.tmaid.2026.102978","pmcid":null,"pmid":"41937023","title":"Potential impact of antimalarial chemoprophylaxis with doxycycline on antimicrobial resistance genes in the enteric microbiome of deployed German soldiers - a case-control-study."}],"sample_intervention_arms":{"antibiotic":26},"sex":{"female":2,"male":50},"title":"Potential impact of doxycycline treatment on antimicrobial resistance genes in the enteric microbiome","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB97980","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB97980_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB97980.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB97980.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB97980.csv.gz"}},{"accession":"PRJNA1076911","age_categories":{"infant":25,"unknown":25},"countries":{"AU":50},"first_public_year":"2024","gbp_per_sample_median":4.18,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"observational_with_procedure","intervention_detail":"Maternal intrapartum/prophylactic antibiotics and caesarean vs vaginal delivery, cohort comparison","interventions":["antibiotic"],"n_samples":50,"papers":[{"doi":"10.1099/mgen.0.001269","pmcid":"PMC11316550","pmid":"38995243","title":"Delivery mode is a larger determinant of infant gut microbiome composition at 6 weeks than exposure to peripartum antibiotics."}],"sample_intervention_arms":{},"sex":{"female":25},"title":"Infant and maternal gut microbiomes","trial_population_condition":"pregnancy_postpartum","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1076911","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1076911_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1076911.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1076911.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1076911.csv.gz"}},{"accession":"PRJNA1153928","age_categories":{"unknown":44},"countries":{"US":44},"first_public_year":"2024","gbp_per_sample_median":2.17,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"other_cancer":44},"intervention_design":"unknown","intervention_detail":"","interventions":[],"n_samples":44,"papers":[{"doi":"10.1136/jitc-2024-011356","pmcid":"PMC12258320","pmid":"40639850","title":"Enhancing outcomes in medically inoperable early-stage NSCLC with gut-targeted antibiotics and stereotactic body radiotherapy: results from a randomized pilot study."}],"sample_intervention_arms":{"antibiotic":19,"no_intervention":25},"sex":{},"title":"Immune System Modulation with Oral Vancomycin in combination with Stereotactic Body Radiotherapy (SBRT) for medically inoperable Early-Stage Non-small Cell Lung Cancer","trial_population_condition":"unknown","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1153928","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1153928_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1153928.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1153928.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1153928.csv.gz"}},{"accession":"PRJNA649316","age_categories":{"adult":43},"countries":{"US":43},"first_public_year":"2020","gbp_per_sample_median":11.14,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":10,"transplant_or_immunocompromised":33},"intervention_design":"observational_with_procedure","intervention_detail":"Multiple courses of antibiotics during HSCT hospitalization in neutropenic patients","interventions":["antibiotic"],"n_samples":43,"papers":[{"doi":"10.1038/s41467-020-18164-7","pmcid":"PMC7463002","pmid":"32873785","title":"Widespread transfer of mobile antibiotic resistance genes within individual gut microbiomes revealed through bacterial Hi-C."},{"doi":"10.7554/elife.66834","pmcid":"PMC8294855","pmid":"34282723","title":"Linking plasmid-based beta-lactamases to their bacterial hosts using single-cell fusion PCR."},{"doi":"10.1099/mgen.0.001030","pmcid":"PMC10327510","pmid":"37272920","title":"Noise reduction strategies in metagenomic chromosome confirmation capture to link antibiotic resistance genes to microbial hosts."}],"sample_intervention_arms":{},"sex":{},"title":"Hi-C and metagenomic sequencing of neutropenic patient microbiomes","trial_population_condition":"transplant_or_immunocompromised","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA649316","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA649316_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA649316.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA649316.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA649316.csv.gz"}},{"accession":"PRJNA761533","age_categories":{"unknown":40},"countries":{"US":40},"first_public_year":"2021","gbp_per_sample_median":4.02,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":true,"health_conditions":{"crohns_disease":12,"healthy_control":23},"intervention_design":"unknown","intervention_detail":"","interventions":[],"n_samples":40,"papers":[],"sample_intervention_arms":{"antibiotic":20,"no_intervention":20},"sex":{},"title":"Metagenome of antimicrobial-treated samples","trial_population_condition":"unknown","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA761533","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA761533_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA761533.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA761533.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA761533.csv.gz"}},{"accession":"PRJNA851177","age_categories":{"adult":40},"countries":{"AU":40},"first_public_year":"2023","gbp_per_sample_median":5.86,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":40},"intervention_design":"randomized_controlled_trial","intervention_detail":"4 weeks low-dose erythromycin or azithromycin in healthy adults; FMT of erythromycin-exposed mouse microbiota into germ-free mice","interventions":["fmt"],"n_samples":40,"papers":[{"doi":"10.1128/spectrum.00831-23","pmcid":"PMC10433835","pmid":"37347185","title":"The Impact of Long-Term Macrolide Exposure on the Gut Microbiome and Its Implications for Metabolic Control."}],"sample_intervention_arms":{"antibiotic":40},"sex":{},"title":"Alteration of the gut microbiome through long-term macrolide therapy and associated changes in systemic immune and metabolic regulation","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA851177","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA851177_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA851177.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA851177.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA851177.csv.gz"}},{"accession":"PRJNA1236935","age_categories":{"unknown":38},"countries":{"BE":38},"first_public_year":"2025","gbp_per_sample_median":5.76,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":38},"intervention_design":"randomized_controlled_trial","intervention_detail":"372 µg/day ciprofloxacin vs placebo for 27 days","interventions":["antibiotic"],"n_samples":38,"papers":[{"doi":"10.1038/s41598-025-18714-3","pmcid":"PMC12504539","pmid":"41057417","title":"Concentrations of ciprofloxacin in food defined as safe alter the gut microbiome and ciprofloxacin susceptibility in humans: an interventional clinical study."}],"sample_intervention_arms":{},"sex":{},"title":"Healthy Food Study","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1236935","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1236935_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1236935.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1236935.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1236935.csv.gz"}},{"accession":"PRJEB35495","age_categories":{"adult":26},"countries":{"US":26},"first_public_year":"2020","gbp_per_sample_median":1.27,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"transplant_or_immunocompromised":26},"intervention_design":"non_randomized_controlled","intervention_detail":"Diet-induced obesity in mice, allo-HSCT, with prophylactic antibiotic treatment vs untreated controls","interventions":["antibiotic"],"n_samples":26,"papers":[{"doi":"10.1126/scitranslmed.aay7713","pmcid":"PMC8525601","pmid":"33239390","title":"Obesity induces gut microbiota alterations and augments acute graft-versus-host disease after allogeneic stem cell transplantation."}],"sample_intervention_arms":{},"sex":{},"title":"Obesity-Induced Microbiome Alterations Result in Severe Gastrointestinal Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation","trial_population_condition":"transplant_or_immunocompromised","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB35495","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB35495_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB35495.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB35495.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB35495.csv.gz"}},{"accession":"PRJNA703034","age_categories":{"adult":18,"elderly":8},"countries":{"US":26},"first_public_year":"2022","gbp_per_sample_median":1.51,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":26},"intervention_design":"single_arm_before_after","intervention_detail":"4 commonly used antibiotic regimens given to healthy volunteers","interventions":["antibiotic"],"n_samples":26,"papers":[{"doi":"10.1016/j.celrep.2022.110649","pmcid":"PMC9066705","pmid":"35417701","title":"Acute and persistent effects of commonly used antibiotics on the gut microbiome and resistome in healthy adults."}],"sample_intervention_arms":{},"sex":{},"title":"Metagenomics of Stool from ICU Patients","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA703034","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA703034_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA703034.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA703034.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA703034.csv.gz"}},{"accession":"PRJNA331073","age_categories":{"unknown":24},"countries":{"IN":24},"first_public_year":"2018","gbp_per_sample_median":8.14,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":6,"other_infection":18},"intervention_design":"observational_with_procedure","intervention_detail":"Anti-tubercular therapy in pulmonary TB patients","interventions":["antibiotic"],"n_samples":24,"papers":[{"doi":"10.1371/journal.pone.0336337","pmcid":"PMC12614512","pmid":"41231796","title":"Exploring gut microbiota and its predicted functions in pulmonary tuberculosis: A multi-regional study using public 16S datasets."},{"doi":"10.1038/s41522-021-00248-x","pmcid":"PMC8497558","pmid":"34620880","title":"Western and non-western gut microbiomes reveal new roles of Prevotella in carbohydrate metabolism and mouth-gut axis."}],"sample_intervention_arms":{},"sex":{},"title":"Gut microbiome of TB patients","trial_population_condition":"other_infection","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA331073","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA331073_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA331073.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA331073.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA331073.csv.gz"}},{"accession":"PRJEB58815","age_categories":{"adult":22},"countries":{"FR":8,"IN":14},"first_public_year":"2023","gbp_per_sample_median":25.08,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":22},"intervention_design":"single_arm_before_after","intervention_detail":"IV cefotaxime or ceftriaxone for 3 days in healthy volunteers, sampled up to day 90","interventions":["antibiotic"],"n_samples":22,"papers":[{"doi":"10.1186/s40168-023-01746-0","pmcid":"PMC10929231","pmid":"38468305","title":"Perturbation and resilience of the gut microbiome up to 3 months after β-lactams exposure in healthy volunteers suggest an important role of microbial β-lactamases."}],"sample_intervention_arms":{},"sex":{},"title":"PREDIRES_phage","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB58815","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB58815_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB58815.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB58815.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB58815.csv.gz"}},{"accession":"PRJEB59728","age_categories":{"unknown":22},"countries":{"CA":22},"first_public_year":"2023","gbp_per_sample_median":1.08,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":22},"intervention_design":"observational_with_procedure","intervention_detail":"Empiric IV β-lactam and/or vancomycin for febrile neutropenia, varying courses/duration","interventions":["antibiotic"],"n_samples":22,"papers":[{"doi":null,"pmcid":null,"pmid":null,"title":""}],"sample_intervention_arms":{},"sex":{},"title":"This study examined pediatric patients undergoing treatment for various cancers and examined the impact of antibiotic use and duration on antibiotic resistance genes","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB59728","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB59728_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB59728.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB59728.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB59728.csv.gz"}},{"accession":"PRJNA835321","age_categories":{"unknown":22},"countries":{"IN":22},"first_public_year":"2023","gbp_per_sample_median":7.02,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"observational_with_procedure","intervention_detail":"Maternal postpartum antibiotic prophylaxis","interventions":["antibiotic"],"n_samples":22,"papers":[],"sample_intervention_arms":{},"sex":{},"title":"Whole metagenome analysis of Infant gut and breast milk microbiota","trial_population_condition":"pregnancy_postpartum","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA835321","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA835321_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA835321.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA835321.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA835321.csv.gz"}},{"accession":"PRJNA613054","age_categories":{"neonate":20},"countries":{"NL":20},"first_public_year":"2022","gbp_per_sample_median":0.06,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"randomized_controlled_trial","intervention_detail":"Randomized IV antibiotics (pen+gent, co-amoxiclav+gent, or amox+cefotaxime) for sEONS vs controls","interventions":["antibiotic"],"n_samples":20,"papers":[{"doi":"10.1038/s41467-022-28525-z","pmcid":"PMC8850541","pmid":"35173154","title":"Effects of early-life antibiotics on the developing infant gut microbiome and resistome: a randomized trial."}],"sample_intervention_arms":{},"sex":{},"title":"Fecal resistome in early life and effects of early life antibiotics, annotated shotgun sequencing data","trial_population_condition":"unknown","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA613054","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA613054_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA613054.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA613054.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA613054.csv.gz"}},{"accession":"PRJNA680579","age_categories":{"unknown":19},"countries":{"US":19},"first_public_year":"2021","gbp_per_sample_median":35.5,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_infection":19},"intervention_design":"single_arm_before_after","intervention_detail":"Longitudinal sampling through antibiotic treatment of one individual","interventions":["antibiotic"],"n_samples":19,"papers":[{"doi":"10.1101/gr.265058.120","pmcid":"PMC8327913","pmid":"34301627","title":"Longitudinal linked-read sequencing reveals ecological and evolutionary responses of a human gut microbiome during antibiotic treatment."},{"doi":"10.1093/gigascience/giae028","pmcid":"PMC11170215","pmid":"38869148","title":"LRTK: a platform agnostic toolkit for linked-read analysis of both human genome and metagenome."}],"sample_intervention_arms":{},"sex":{},"title":"Longitudinal linked read sequencing reveals ecological and evolutionary responses of a human gut microbiome during antibiotic treatment","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA680579","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA680579_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA680579.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA680579.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA680579.csv.gz"}},{"accession":"PRJNA342339","age_categories":{"elderly":18},"countries":{"CH":18},"first_public_year":"2016","gbp_per_sample_median":0.0,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"healthy_control":18},"intervention_design":"observational_with_procedure","intervention_detail":"","interventions":[],"n_samples":18,"papers":[{"doi":"10.1186/s13099-016-0144-y","pmcid":"PMC5133761","pmid":"27980686","title":"Clostridium difficile colonization and antibiotics response in PolyFermS continuous model mimicking elderly intestinal fermentation."}],"sample_intervention_arms":{"antibiotic":6,"no_intervention":12},"sex":{"female":18},"title":"Metagenome of fermentation model samples inoculated with human feces","trial_population_condition":"gi_infection_or_diarrhoea","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA342339","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA342339_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA342339.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA342339.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA342339.csv.gz"}},{"accession":"PRJEB28730","age_categories":{"adult":17},"countries":{"DE":17},"first_public_year":"2019","gbp_per_sample_median":7.64,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"single_arm_before_after","intervention_detail":"Ceftriaxone (cephalosporin antibiotic) challenge, time-series stool sampling pre/post","interventions":["antibiotic"],"n_samples":17,"papers":[{"doi":"10.1136/gutjnl-2018-317715","pmcid":"PMC6839795","pmid":"30658995","title":"Antibiotics-induced monodominance of a novel gut bacterial order."}],"sample_intervention_arms":{"antibiotic":16},"sex":{"male":11},"title":"Metagenomic stool samples in time series","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB28730","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB28730_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB28730.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB28730.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB28730.csv.gz"}},{"accession":"PRJDB39536","age_categories":{"unknown":15},"countries":{},"first_public_year":"2026","gbp_per_sample_median":68.43,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":15,"papers":[{"doi":"10.1101/2024.09.10.612220","pmcid":null,"pmid":null,"title":"Large-scale single-cell long-read genomics enables high-resolution microbiome profiling"}],"sample_intervention_arms":{"antibiotic":6,"fmt":4,"no_intervention":5},"sex":{},"title":"Large-scale single-cell long-read genomics enables high-resolution microbiome profiling (PRJCA047574)","trial_population_condition":"unknown","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJDB39536","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJDB39536_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJDB39536.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJDB39536.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJDB39536.csv.gz"}},{"accession":"PRJEB21338","age_categories":{"unknown":15},"countries":{"RU":15},"first_public_year":"2017","gbp_per_sample_median":1.7,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"gi_infection_or_diarrhoea":15},"intervention_design":"single_arm_before_after","intervention_detail":"H. pylori eradication therapy with two broad-spectrum antibiotics, sampled before/after","interventions":["antibiotic"],"n_samples":15,"papers":[{"doi":"10.1016/j.dib.2017.07.070","pmcid":"PMC5554923","pmid":"28831408","title":"Shotgun metagenomic data on the human stool samples to characterize shifts of the gut microbial profile after the Helicobacter pylori eradication therapy."}],"sample_intervention_arms":{},"sex":{"female":6,"male":9},"title":"Shotgun metagenomic data of fecal microbiota of patients with H. pylori infection before and after eradication therapy","trial_population_condition":"gi_infection_or_diarrhoea","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB21338","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB21338_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB21338.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB21338.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB21338.csv.gz"}},{"accession":"PRJNA573821","age_categories":{"adult":15},"countries":{"HK":15},"first_public_year":"2020","gbp_per_sample_median":5.43,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":15},"intervention_design":"single_arm_before_after","intervention_detail":"Augmentin, Azithromycin, Levofloxacin given over 6 days","interventions":["antibiotic"],"n_samples":15,"papers":[{"doi":"10.1186/s40168-020-00899-6","pmcid":"PMC7488854","pmid":"32919472","title":"Antibiotics create a shift from mutualism to competition in human gut communities with a longer-lasting impact on fungi than bacteria."}],"sample_intervention_arms":{"antibiotic":15},"sex":{},"title":"Whole Meta-genome shotgun sequencing of stool samples from human treated with antibiotics","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA573821","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA573821_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA573821.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA573821.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA573821.csv.gz"}},{"accession":"PRJDB10484","age_categories":{"unknown":12},"countries":{"JP":12},"first_public_year":"2022","gbp_per_sample_median":14.51,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"liver_disease":12},"intervention_design":"observational_with_procedure","intervention_detail":"Rifaximin (nonabsorbable antibiotic) administration in HE patients","interventions":["antibiotic"],"n_samples":12,"papers":[{"doi":"10.1002/hep4.1954","pmcid":"PMC9315133","pmid":"35429147","title":"Distinct responsiveness to rifaximin in patients with hepatic encephalopathy depends on functional gut microbial species."}],"sample_intervention_arms":{},"sex":{},"title":"Gut microbial species responsible for hyperammonemia-related urease activity in hepatic encephalopathy patients","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJDB10484","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJDB10484_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJDB10484.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJDB10484.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJDB10484.csv.gz"}},{"accession":"PRJEB10391","age_categories":{"adult":12},"countries":{"DE":12},"first_public_year":"2015","gbp_per_sample_median":6.62,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"single_arm_before_after","intervention_detail":"Ciprofloxacin 500 mg orally twice daily for 6 days","interventions":["antibiotic"],"n_samples":12,"papers":[{"doi":"10.1128/aac.01504-15","pmcid":"PMC4649198","pmid":"26369961","title":"Antibiotic Selection Pressure Determination through Sequence-Based Metagenomics."},{"doi":"10.1016/j.chom.2021.05.008","pmcid":"PMC8288446","pmid":"34111423","title":"Dispersal strategies shape persistence and evolution of human gut bacteria."}],"sample_intervention_arms":{"antibiotic":6,"no_intervention":2},"sex":{"male":12},"title":"Impact of ciprofloxacin pertubation on the intestinal resistome and microbiota in two healthy volunteers","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB10391","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB10391_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB10391.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB10391.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB10391.csv.gz"}},{"accession":"PRJEB5771","age_categories":{"unknown":12},"countries":{"DE":12},"first_public_year":"2014","gbp_per_sample_median":0.03,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"gi_infection_or_diarrhoea":6},"intervention_design":"observational_with_procedure","intervention_detail":"Antibiotic therapy; samples before, during, after AB treatment, CDI vs non-infected","interventions":[],"n_samples":12,"papers":[{"doi":"10.3389/fmicb.2014.00335","pmcid":"PMC4163665","pmid":"25309515","title":"Structural and functional changes in the gut microbiota associated to Clostridium difficile infection."}],"sample_intervention_arms":{"antibiotic":3},"sex":{},"title":"Human gut microbiota associated to Clostridium difficile infection","trial_population_condition":"gi_infection_or_diarrhoea","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB5771","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB5771_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB5771.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB5771.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB5771.csv.gz"}},{"accession":"PRJEB80456","age_categories":{"unknown":12},"countries":{"US":12},"first_public_year":"2024","gbp_per_sample_median":35.15,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"single_arm_before_after","intervention_detail":"Autologous FMT after amoxicillin treatment in infant","interventions":["antibiotic","fmt"],"n_samples":12,"papers":[{"doi":"10.1128/mbio.00711-26","pmcid":"PMC13343926","pmid":"42214386","title":"Autologous fecal microbiota transplantation restores the infant gut microbiome and metabolome after antibiotics: a case report."}],"sample_intervention_arms":{},"sex":{},"title":"afmt sample deep sequencing metagenomic and HiC","trial_population_condition":"preterm_nicu","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB80456","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB80456_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB80456.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB80456.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB80456.csv.gz"}},{"accession":"PRJNA613032","age_categories":{"infant":2,"unknown":10},"countries":{"NL":12},"first_public_year":"2022","gbp_per_sample_median":0.4,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"randomized_controlled_trial","intervention_detail":"Penicillin+gentamicin vs co-amoxiclav+gentamicin vs amoxicillin+cefotaxime for sEONS","interventions":["antibiotic"],"n_samples":12,"papers":[{"doi":"10.1038/s41467-022-28525-z","pmcid":"PMC8850541","pmid":"35173154","title":"Effects of early-life antibiotics on the developing infant gut microbiome and resistome: a randomized trial."}],"sample_intervention_arms":{},"sex":{"female":1,"male":1},"title":"Fecal microbiota in early life and effects of early life antibiotics, annotated shotgun sequencing data","trial_population_condition":"sepsis_or_infection","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA613032","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA613032_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA613032.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA613032.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA613032.csv.gz"}},{"accession":"PRJEB86834","age_categories":{"adult":4,"elderly":3,"unknown":4},"countries":{"RU":11},"first_public_year":"2025","gbp_per_sample_median":10.23,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"other_infection":11},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":11,"papers":[{"doi":"10.1128/msphere.00139-26","pmcid":"PMC13317233","pmid":"42153646","title":"Gut Hi-C metagenomes of severe COVID-19 patients: bacteria and yeast involved in gut-lung axis."}],"sample_intervention_arms":{"antibiotic":4,"no_intervention":7},"sex":{"female":4,"male":5},"title":"Hi-C metagenomic reconstruction of bacterial and fungal microbiome colonizing gut-lung axis in severe-ill patients","trial_population_condition":"other_infection","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB86834","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB86834_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB86834.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB86834.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB86834.csv.gz"}},{"accession":"PRJEB18265","age_categories":{"adult":4,"unknown":6},"countries":{"RU":10},"first_public_year":"2016","gbp_per_sample_median":9.26,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"single_arm_before_after","intervention_detail":"Quadruple H. pylori eradication antibiotic therapy, pre/post sampling","interventions":["antibiotic"],"n_samples":10,"papers":[{"doi":"10.1016/j.dib.2017.01.007","pmcid":"PMC5256668","pmid":"28138506","title":"Data on gut metagenomes of the patients with Helicobacter pylori infection before and after the antibiotic therapy."},{"doi":"10.3389/fmicb.2019.01902","pmcid":"PMC6718723","pmid":"31507546","title":"Shifts in the Human Gut Microbiota Structure Caused by Quadruple Helicobacter pylori Eradication Therapy."},{"doi":"10.1128/msystems.01468-21","pmcid":"PMC9052204","pmid":"35258340","title":"Quantifying and Cataloguing Unknown Sequences within Human Microbiomes."}],"sample_intervention_arms":{},"sex":{"female":2,"male":2},"title":"Estimation of variability in the gut microbiota resistome of the Russian citizens aimed at identification of pathways for transmission and spread of antibiotic resistance.","trial_population_condition":"gi_infection_or_diarrhoea","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB18265","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB18265_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB18265.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB18265.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB18265.csv.gz"}},{"accession":"PRJNA685914","age_categories":{"unknown":9},"countries":{"DE":2,"ES":1,"GR":1,"RO":5},"first_public_year":"2021","gbp_per_sample_median":1.26,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"observational_with_procedure","intervention_detail":"Broad-spectrum antibiotics (beta-lactams, carbapenems, fluoroquinolones, clindamycin) in hospitalized patients, sampled pre/post treatment","interventions":["antibiotic"],"n_samples":9,"papers":[{"doi":"10.1038/s41467-021-22269-y","pmcid":"PMC8046770","pmid":"33854064","title":"Incidence and predictive biomarkers of Clostridioides difficile infection in hospitalized patients receiving broad-spectrum antibiotics."},{"doi":"10.1038/s41467-021-22302-0","pmcid":"PMC8047037","pmid":"33854066","title":"Microbiota-based markers predictive of development of Clostridioides difficile infection."},{"doi":"10.1016/j.cell.2024.12.017","pmcid":"PMC11848717","pmid":"39848248","title":"Integration of 168,000 samples reveals global patterns of the human gut microbiome."},{"doi":"10.1186/s12859-025-06217-x","pmcid":"PMC12281747","pmid":"40691525","title":"metaGEENOME: an integrated framework for differential abundance analysis of microbiome data in cross-sectional and longitudinal studies."},{"doi":"10.1038/s44259-026-00199-3","pmcid":"PMC13190808","pmid":"42103940","title":"Phenotypic convergence and collateral susceptibility development in Pseudomonas aeruginosa under antibiotic exposure in ICU patients."}],"sample_intervention_arms":{},"sex":{},"title":"Microbiota-based markers predictive of development of Clostridioides difficile infection","trial_population_condition":"gi_infection_or_diarrhoea","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA685914","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA685914_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA685914.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA685914.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA685914.csv.gz"}},{"accession":"PRJNA392494","age_categories":{"unknown":7},"countries":{"ES":7},"first_public_year":"2017","gbp_per_sample_median":0.48,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":7},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":7,"papers":[],"sample_intervention_arms":{"antibiotic":1,"no_intervention":1},"sex":{},"title":"Phageome in fecal samples","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA392494","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA392494_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA392494.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA392494.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA392494.csv.gz"}},{"accession":"PRJNA446061","age_categories":{"adult":7},"countries":{"US":7},"first_public_year":"2018","gbp_per_sample_median":0.7,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":7},"intervention_design":"randomized_controlled_trial","intervention_detail":"5 days Amox-Clav then randomized autoFMT enema vs saline enema","interventions":["antibiotic","fmt"],"n_samples":7,"papers":[{"doi":"10.1128/mspheredirect.00588-18","pmcid":"PMC6249645","pmid":"30463925","title":"Impact of Amoxicillin-Clavulanate followed by Autologous Fecal Microbiota Transplantation on Fecal Microbiome Structure and Metabolic Potential."}],"sample_intervention_arms":{},"sex":{},"title":"Fecal Metagenome","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA446061","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA446061_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA446061.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA446061.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA446061.csv.gz"}},{"accession":"PRJEB3085","age_categories":{"elderly":6},"countries":{"DE":6},"first_public_year":"2013","gbp_per_sample_median":0.0,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":6},"intervention_design":"single_arm_before_after","intervention_detail":"","interventions":[],"n_samples":6,"papers":[{"doi":"10.1136/gutjnl-2012-303184","pmcid":"PMC3812899","pmid":"23236009","title":"Gut microbiota disturbance during antibiotic therapy: a multi-omic approach."},{"doi":"10.3389/fmicb.2014.00335","pmcid":"PMC4163665","pmid":"25309515","title":"Structural and functional changes in the gut microbiota associated to Clostridium difficile infection."}],"sample_intervention_arms":{"antibiotic":6},"sex":{"male":6},"title":"Disturbance of the gut microbiota during antibiotic stress (therapy): a multi-omic approach","trial_population_condition":"other_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB3085","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB3085_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB3085.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB3085.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB3085.csv.gz"}},{"accession":"PRJEB31957","age_categories":{"child":6},"countries":{"NO":6},"first_public_year":"2019","gbp_per_sample_median":7.67,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_infection":6},"intervention_design":"single_arm_before_after","intervention_detail":"","interventions":[],"n_samples":6,"papers":[{"doi":"10.1016/j.jgar.2019.08.004","pmcid":null,"pmid":"31415828","title":"Impact of narrow-spectrum penicillin V on the oral and faecal resistome in a young child treated for otitis media."},{"doi":"10.1101/672196","pmcid":null,"pmid":null,"title":"Impact of narrow spectrum Penicillin V on the oral and fecal resistome in a young child treated for otitis media"}],"sample_intervention_arms":{"antibiotic":2,"no_intervention":2},"sex":{},"title":"Impact of narrow-spectrum antibiotics on the oral and fecal microbiome and resistome in a young child treated for otitis media","trial_population_condition":"other_infection","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB31957","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB31957_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB31957.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB31957.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB31957.csv.gz"}},{"accession":"PRJNA1468588","age_categories":{"adult":4},"countries":{"US":4},"first_public_year":"2026","gbp_per_sample_median":13.86,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"liver_disease":4},"intervention_design":"single_arm_before_after","intervention_detail":"Vancomycin treatment, longitudinal case study","interventions":["antibiotic"],"n_samples":4,"papers":[{"doi":"10.1093/ecco-jcc/jjag099","pmcid":null,"pmid":"42490468","title":"Rapid resolution of colon inflammation and microbiome remodeling with vancomycin therapy in a patient with primary sclerosing cholangitis."}],"sample_intervention_arms":{"antibiotic":3,"no_intervention":1},"sex":{},"title":"Gut microbiome dynamics in a primary sclerosing cholangitis patient treated with vancomycin","trial_population_condition":"autoimmune_inflammatory","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1468588","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1468588_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1468588.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1468588.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1468588.csv.gz"}},{"accession":"PRJNA298489","age_categories":{"adult":4},"countries":{"ES":4},"first_public_year":"2015","gbp_per_sample_median":9.9,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":4},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":4,"papers":[{"doi":"10.1073/pnas.1519288112","pmcid":"PMC4653211","pmid":"26512100","title":"Library preparation methodology can influence genomic and functional predictions in human microbiome research."},{"doi":"10.1186/s12864-017-3679-5","pmcid":"PMC5390407","pmid":"28407798","title":"Utilization of defined microbial communities enables effective evaluation of meta-genomic assemblies."},{"doi":"10.1128/msystems.01468-21","pmcid":"PMC9052204","pmid":"35258340","title":"Quantifying and Cataloguing Unknown Sequences within Human Microbiomes."}],"sample_intervention_arms":{"antibiotic":2},"sex":{"female":4},"title":"Library preparation methodology can influence genomic and functional predictions in human microbiome research","trial_population_condition":"unknown","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA298489","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA298489_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA298489.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA298489.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA298489.csv.gz"}},{"accession":"PRJNA1241450","age_categories":{"adult":3},"countries":{"US":3},"first_public_year":"2025","gbp_per_sample_median":4.36,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_infection":3},"intervention_design":"single_arm_before_after","intervention_detail":"","interventions":[],"n_samples":3,"papers":[],"sample_intervention_arms":{"antibiotic":2,"no_intervention":1},"sex":{"female":3},"title":"Oral Antibiotic Human Case Study","trial_population_condition":"unknown","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1241450","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1241450_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1241450.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1241450.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1241450.csv.gz"}},{"accession":"PRJNA414540","age_categories":{"adult":2},"countries":{"CA":2},"first_public_year":"2017","gbp_per_sample_median":58.3,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":2},"intervention_design":"randomized_controlled_trial","intervention_detail":"Probiotic (L. rhamnosus/L. helveticus) vs placebo following amoxicillin-clavulanic acid in healthy adults","interventions":["antibiotic","probiotic"],"n_samples":2,"papers":[{"doi":"10.1038/s41598-018-29229-5","pmcid":"PMC6060159","pmid":"30046129","title":"Gut Bacterial Microbiota and its Resistome Rapidly Recover to Basal State Levels after Short-term Amoxicillin-Clavulanic Acid Treatment in Healthy Adults."},{"doi":"10.1093/gigascience/giz146","pmcid":"PMC6901069","pmid":"31816087","title":"Systematic processing of ribosomal RNA gene amplicon sequencing data."}],"sample_intervention_arms":{},"sex":{},"title":"human gut metagenome Raw sequence reads","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA414540","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA414540_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA414540.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA414540.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA414540.csv.gz"}},{"accession":"PRJNA678582","age_categories":{"adult":1},"countries":{"US":1},"first_public_year":"2020","gbp_per_sample_median":3.65,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"single_arm_before_after","intervention_detail":"Rifaximin 8-week open-label trial in compensated cirrhosis, pre/post ARG comparison","interventions":["antibiotic"],"n_samples":1,"papers":[{"doi":"10.1053/j.gastro.2021.04.013","pmcid":"PMC9069394","pmid":"33857456","title":"Impact of Antibiotic Resistance Genes in Gut Microbiome of Patients With Cirrhosis."}],"sample_intervention_arms":{},"sex":{},"title":"Cirrhosis metagenomics","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA678582","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA678582_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA678582.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA678582.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA678582.csv.gz"}}],"release":"R2026.25"}